<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Veterinary medicinal products (A8-0046/2016 - Françoise Grossetête) - Thursday, 10 March 2016</title><meta name="title" content="Verbatim report of proceedings - Veterinary medicinal products (A8-0046/2016 - Françoise Grossetête) - Thursday, 10 March 2016" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2016 - Source: European Parliament" /><meta name="available" content="10-03-2016" /><meta name="sipade-leg" content="8" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Veterinary medicinal products (A8-0046/2016 - Françoise Grossetête) - Thursday, 10 March 2016" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-8-2016-03-10-ITM-008-02_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-8-2016-03-10-ITM-008-02_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-03-10-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-03-10-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-03-10-ITM-008-01_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-03-10-ITM-008-01_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-8-2016-03-10-ITM-008-03_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-8-2016-03-10-ITM-008-03_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-03-10_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-03-10_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2014/0257(COD)">2014/0257(COD)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A8-0046/2016</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-8-2016-0046_EN.html" class="ring_ref_link">A8-0046/2016</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p>
                        <a href="/doceo/document/PV-8-2016-03-09-ITM-020_EN.html" class="ring_ref_link">PV 09/03/2016 - 20</a><br />
                        <a href="/doceo/document/CRE-8-2016-03-09-ITM-020_EN.html" class="ring_ref_link">CRE 09/03/2016 - 20</a><br />
                        <a href="/doceo/document/PV-8-2018-10-24-ITM-020_EN.html" class="ring_ref_link">PV 24/10/2018 - 20</a><br />
                        <a href="/doceo/document/CRE-8-2018-10-24-ITM-019_EN.html" class="ring_ref_link">CRE 24/10/2018 - 19</a><br />
                        <a href="/doceo/document/CRE-8-2018-10-24-ITM-020_EN.html" class="ring_ref_link">CRE 24/10/2018 - 20</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-8-2016-03-10-ITM-007-05_EN.html" class="ring_ref_link">PV 10/03/2016 - 7.5</a><br />
                        <a href="/doceo/document/CRE-8-2016-03-10-ITM-007-05_EN.html" class="ring_ref_link">CRE 10/03/2016 - 7.5</a><br />
                        <a class="ring_ref_selected">Explanations of votes</a><br />
                        <a href="/doceo/document/PV-8-2018-10-25-ITM-013-05_EN.html" class="ring_ref_link">PV 25/10/2018 - 13.5</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-8-2016-0087_EN.html" class="ring_ref_link">P8_TA(2016)0087</a><br />
                        <a href="/doceo/document/TA-8-2018-0421_EN.html" class="ring_ref_link">P8_TA(2018)0421</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 10 March 2016 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 8.2. Veterinary medicinal products (<a href="/doceo/document/A-8-2016-0046_EN.html">A8-0046/2016</a> - Françoise Grossetête)</td></tr></table>
<a name="4-231-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20160310-13:07:11&amp;playerEndTime=20160310-13:07:17" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Explicații orale privind votul</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-232-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124746.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20160310-13:07:17&amp;playerEndTime=20160310-13:08:11" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andrejs Mamikins (S&amp;D).</span></span>   <span class="bold">–</span> Priekšsēdētāj! Šis priekšlikums apzīmē kārtējo Eiropas Savienības centienu tālāk attīstīt Kopienas likumdošanu attiecībā uz mums blakus dzīvojošiem dzīvniekiem, jo principā veterinārās zāles bieži vien pielietotas ne tāpēc, lai ārstētu vai uzlabotu dzīvnieku veselību, bet arī, lai garantētu veselību mums, cilvēkiem — tātad dzīvnieku produktu patērētājiem.</p>
<p class="contents">Galvenais mērķis, ko šīs normatīvās rezolūcijas projekts cenšas risināt, ir uzlabot piekļuvi nepieciešamām zālēm un samazināt attiecīgās jomas administratīvo slogu, sekmēt inovāciju, konkurētspēju, kā arī nodrošināt efektīvu veterināro zāļu tirgus darbību Kopienas ietvaros, kā arī cīnīties ar rezistenci pret antibiotikām. Pēdējais jautājums, starp citu, jau tika apspriests pirmdien plenārsesijas laikā. Šis ir ļoti svarīgs dokuments, un tāpēc es nobalsoju par. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-233-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96772.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20160310-13:08:13&amp;playerEndTime=20160310-13:09:27" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Peter Jahr (PPE).</span></span>   <span class="bold">–</span> Herr Präsident! Die Landwirtschaft stellt sich ihrer Verantwortung. Wir müssen beim Einsatz von Tierarzneimitteln zwei Dinge beachten. Erstens: Der Einsatz muss angemessen sein. Der Einsatz muss sich am Tierwohl orientieren. Zweitens: Wir müssen natürlich auch auf mögliche Nebenwirkungen im Humanbereich achten. Stichworte: Reserveantibiotika und Antibiotikaresistenz.</p>
<p class="contents">Natürlich ist die Landwirtschaft nur ein Teil des Problems. Aber auch wenn man nur ein Teil des Problems ist, muss man natürlich auch diesen Teilbereich lösen. Ich denke, wir sind dabei, mit diesem Bericht gute Kompromisse zu finden: Wir wollen den Internethandel von Antibiotika verbieten, wir wollen den Einsatz von Antibiotika minimieren, und wir haben besonders beim Einsatz von Reserveantibiotika quasi ein doppeltes Genehmigungsverfahren eingeführt, was diese besonders wichtigen Medikamente im Einsatz wirklich begrenzt.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20160310-13:09:26&amp;playerEndTime=20160310-13:09:39" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Explicații scrise privind votul</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125045.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Clara Eugenia Aguilera García (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establezca la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales. Quisiera destacar la dificultad que existe para encontrar medicamentos para determinadas especies de animales y usos menores y me alegro de que el procedimiento de cascada incluido haya mejorado la propuesta de la Comisión Europea. Además, se apuesta por la investigación y la innovación entre otras propuestas con el incremento del tiempo por el generador de la patente. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96897.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">John Stuart Agnew (EFDD),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/99650.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tim Aker (EFDD),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines including antibiotics should be used responsibly, under veterinary care and according to licensing conditions. We believe that the British Parliament should be able to legislate on this issue without being overruled by the unelected EU Commission.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125048.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marina Albiol Guzmán (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor del presente informe porque considero que, pese a que discrepo en importantes puntos, supone una mejora de la legislación en este ámbito en un momento de vigente necesidad. El informe incluye referencias muy positivas al papel exclusivo que deben desempeñar los veterinarios en la prescripción de este tipo de medicamentos; igualmente el informe se refiere positivamente a la necesidad de evaluar el impacto ambiental de los medicamentos en el medio ambiente, la inclusión de las pequeñas y medianas empresas, la prevención de sufrimientos innecesarios en los animales, etc. Este Reglamento resulta muy necesario frente a las crisis que está sufriendo el sector ganadero, con elementos como la extensión de la tuberculosis entre otras enfermedades que necesitan la disponibilidad de este tipo de medicamentos veterinarios. Es por todo esto por lo que he decidido votar a favor del presente informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-234-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/doceo/data/img/photo_generic.gif" align="right" width="50" height="63" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Martina Anderson, Lynn Boylan and Liadh Ní Riada (GUE/NGL),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> We voted in favour of this report on veterinary medicinal products. Whilst a shorter length of patent protection would have been preferable to allow more affordable generics to enter the market sooner, overall this report is a positive step forward in the field of veterinary medicines. One of the key issues for both human and animal health addressed in this report is antimicrobial resistance, with a proposal for a strict limit on prophylactic use where antibiotics are applied to healthy animals – a process with worrying implications for antibiotic resistance, especially for vital antimicrobial medicines uses for humans.</p>
<p class="contents">With the WHO warning that the world is on the cusp of entering a post-antibiotic era with grave implications for human health, it is essential that we act now and take measures to effectively tackle the very dangerous risks we face if we do not face up to the threat of antibiotic resistance.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-235-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125110.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νίκος Ανδρουλάκης (</span></span>  <span class="bold">S</span><span class="bold">&amp;</span><span class="bold">D</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Η έκθεση για τα κτηνιατρικά φάρμακα περιλαμβάνει την εναρμόνιση των απαιτήσεων της κτηνιατρικής συνταγής και την αναγνώριση των συνταγών σε όλα τα κράτη μέλη, πάντα σε ευθυγράμμιση με την εκάστοτε εθνική νομοθεσία. Ακόμη, περιλαμβάνει την τόνωση της καινοτομίας και την ανάπτυξη νέων κτηνιατρικών φαρμάκων, καθώς και την εναρμόνιση των περιόδων προστασίας των νέων πακέτων δεδομένων που σχετίζονται με τα αντιμικροβιακά κτηνιατρικά φαρμακευτικά προϊόντα (πατέντες). Η έκθεση αναφέρεται στη δράση για τη μείωση της χρήσης των αντιβιοτικών και ορίζει τις απαιτήσεις για την επισήμανση συσκευασία. Επίσης, απλοποιεί τις απαιτήσεις σχετικά με τις αιτήσεις για τις περιορισμένες αγορές, διευκολύνει την κυκλοφορία κτηνιατρικών φαρμάκων σε ολόκληρη την ΕΕ με σαφείς κανόνες για τις διαδικτυακές πωλήσεις και περιλαμβάνει την αντιμετώπιση του κινδύνου για τη δημόσια υγεία στην ανθεκτικότητα στα μικρόβια. Υπερψήφισα την έκθεση, με σκοπό να υπάρχει ένας κανονισμός που παρέχει καλύτερη πρόσβαση στα κτηνιατρικά φάρμακα, θα λαμβάνει μέτρα για την καταπολέμηση της μικροβιακής ανθεκτικότητας, θα μειώνει τον διοικητικό φόρτο, και θα προωθεί την καινοτομία και την ανταγωνιστικότητα του τομέα.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-235-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/24922.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Pascal Arimont (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Angesichts der Tatsache, dass laut WHO in der EU jährlich 25.000 Menschen sterben, weil Antibiotika ihre Wirkung verlieren, ist es notwendig, im Kampf gegen Antibiotikaresistenzen Ernst zu machen. Deshalb ist es auch so wichtig, bei der Tiermedizin anzusetzen, weil bei Tieren ebenfalls antibiotikaresistente Keime entstehen können, die auf den Menschen übergreifen können. Konkret sieht die Verordnungsüberarbeitung vor, dass die Verwendung bestehender antimikrobieller Medikamente eingeschränkt und die Entwicklung neuer Wirkstoffe vorangebracht werden. Aus diesen Gründen begrüße ich den vorliegenden Text.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-235-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124748.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marie-Christine Arnautu (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Ce rapport prévoit de centraliser autant que possible les autorisations de médicaments vétérinaires vers une agence européenne. Si certaines propositions viennent amender dans le bon sens la proposition, cela permettra tout de même de retirer aux États membres leurs prérogatives et leur expertise propres par ce transfert de compétence.</p>
<p class="contents">J'ai voté contre ce texte.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-235-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124773.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean Arthuis (ALDE), </span></span>  <span class="italic">par écrit. ‒ </span>Ce projet de règlement vise à régir l'autorisation, la fabrication, la mise sur le marché, la distribution et l'utilisation des médicaments vétérinaires. </p>
<p class="contents">J'ai voté en faveur de cette délibération, car elle différencie le marché des médicaments vétérinaires de celui des médicaments humains, qui répondent à des logiques très différentes. De plus, le texte permettra d'améliorer la disponibilité des produits et la simplification administrative, sans pour autant sacrifier les impératifs de santé publique et de protection de l'environnement. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-235-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28292.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Inés Ayala Sender (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establezca la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96680.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Zigmantas Balčytis (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau už šį siūlymą dėl veterinarinių vaistų, kuriuo siekiama mažinti antibiotikų vartojimą gyvulininkystėje. Bakterijos tampa vis atsparesnės, todėl reikia apriboti antibiotikų vartojimą gyvulininkystėje bei kurti naujo tipo vaistus. Nauju siūlymu skatinami naujoviškų vaistų tyrimai ir ribojamas prevencinis antibiotikų skyrimas gyvūnams. Juo siekiama reglamentuoti veterinarinių vaistų leidimų suteikimą, gamybą, rinkodarą, veterinarinių vaistų platinimą ir naudojimą visu jų galiojimo laikotarpiu, taip pat jiems taikomą farmakologinio budrumo procesą. Europos Komisija siūlo pagerinti galimybes gauti vaistų ir jų prieinamumą, ypač nepagrindinių rūšių gyvūnams, sumažinti administracinę naštą, ypač susijusią su farmakologinio budrumo procesu, skatinti inovacijas šiame sektoriuje ir jo konkurencingumą, užtikrinti gerą veterinarinių vaistų vidaus rinkos veikimą bei kovoti su atsparumu antibiotikams. Pritariu išdėstytiems siūlymams, kad nuostatos dėl kovos su atsparumu antimikrobinėms medžiagoms turėtų būti platesnio užmojo ir turėtų būti įtrauktos aiškios skirtingų gydymo būdų apibrėžtys, o profilaktinis antibakterinių medžiagų naudojimas turėtų būti uždraustas. Taip pat būtina sustiprinti skatinamąsias priemones, skirtas inovacijoms remti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124760.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolas Bay (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Le texte vise à réglementer la mise sur le marché et la circulation des médicaments vétérinaires. Les grandes préoccupations qui ont sous-tendu les propositions sont la lutte contre l'antibiorésistance et l'assurance de la meilleure disponibilité possible des médicaments. Cependant, sous cet objectif se cache en fait une libéralisation de la vente des médicaments, notamment par des sites de vente en ligne, soustrayant ainsi cette source de revenus aux vétérinaires, pourtant plus à même de délivrer les produits en question. </p>
<p class="contents">Même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelles sanitaires. Il autorise en outre la prescription de certains médicaments par des non-vétérinaires, ce qui est inacceptable pour des raisons de santé publique. J'ai donc voté contre.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125002.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Hugues Bayet (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de ce rapport relatif à une proposition de directive qui vise à mettre en place un corpus législatif actualisé, adapté aux spécificités du secteur vétérinaire, tout en préservant la santé publique, la santé animale, la sécurité des denrées alimentaires et l'environnement.</p>
<p class="contents">La rapporteure partage les objectifs de la Commission ainsi que sa volonté de bien différencier le marché des médicaments vétérinaires de celui des médicaments humains, qui répond à une logique très différente. De même, la Commission a choisi de mettre l'accent sur la disponibilité des produits et sur la simplification administrative, sans pour autant sacrifier les impératifs de santé publique et de protection de l'environnement.</p>
<p class="contents">Toutefois, la Commission n'est pas allée assez loin sur certains points. Le projet de rapport précise ainsi les conditions dans lesquelles les professionnels de santé vétérinaire sont autorisés à prescrire et à vendre des antibiotiques ou souligne que les antibiotiques et médicaments ne peuvent être vendus par internet.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124867.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Brando Benifei (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Oggi ho votato a favore della relazione Grossetête sulla proposta di regolamento sui medicinali veterinari. </p>
<p class="contents">I medicinali riservati agli animali sono strumenti importanti che richiedono un'elaborazione particolarmente complessa a causa della molteplicità delle specie esistenti. L'intervento legislativo in questa materia deve tenere conto di due aspetti, da un lato la necessità di semplificare il più possibile la legislazione e dall'altro quello di affrontare la grave questione dell'aumento della resistenza ai farmaci antimicrobici. Lo sviluppo di batteri resistenti deve comportare non solo una limitazione dell'uso dei farmaci antimicrobici, ma soprattutto un investimento in innovazione che consenta di potenziare la ricerca in questo settore. </p>
<p class="contents">L'OMS ha già denunciato i rischi per la salute e la vita di milioni di persone, che potrebbero derivare dall'affermarsi di un'era post-antibiotica. L'Europa deve fare la sua parte, bloccando i trattamenti di massa e assicurando un limitato uso profilattico degli antibiotici per i soli casi in cui esso appare realmente giustificato. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/135490.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Xabier Benito Ziluaga (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Hemos votado A FAVOR de este informe dado que apunta a un mayor control tanto del ciclo de venta de los antibióticos como del uso de los mismos. Limita la venta en internet de medicinas que deberían venderse con prescripción médica, se limita y controla el uso de forma preventiva y se refiere a otras cuestiones que atañen a criterios de bienestar animal. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-236-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96922.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Izaskun Bilbao Barandica (ALDE), </span></span>  <span class="italic">por escrito. ‒ </span>Felicito a la ponente por su excelente trabajo en esta propuesta de Reglamento sobre medicamentos veterinarios, que he apoyado. De la misma forma he votado para que aquellos medicamentos que estén modificados genéticamente no se utilicen, tal y como lo he hecho en anteriores ocasiones en lo relativo a los organismos genéticamente modificados.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-237-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124771.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Bilde (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Je n'ai pas pu soutenir ce rapport qui, s'il affiche des objectifs louables, porte en fait un risque d'atteinte aux intérêts de nos vétérinaires et à notre sécurité sanitaire, voire alimentaire.</p>
<p class="contents">Certes, le texte met en lumière de justes préoccupations comme la lutte contre l'antibiorésistance ou la nécessité d'une meilleure disponibilité des médicaments.</p>
<p class="contents">Cependant, derrière ces justes causes se cachent une tentative de libéralisation de la vente des médicaments, par le biais des sites de vente en ligne notamment, ce qui conduira non seulement à une précarisation de nos vétérinaires mais pourrait également mettre en danger notre sécurité sanitaire, en permettant la prescription de certains médicaments par des non-vétérinaires.</p>
<p class="contents">Enfin, même s'il est plus restrictif que la proposition de la Commission, il est regrettable que ce rapport ne contiennent pas quelques dispositions indispensables telles que: l'interdiction des animaux dans la chaîne alimentaire s'ils ont participé à des essais clinique ou encore l'interdiction de la vente en ligne de médicaments sur prescription, en particulier pour les animaux producteurs d'aliments.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-238-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125044.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">J</span></span>  <span class="bold">osé Blanco López (S&amp;D), </span><span class="italic">por escrito. ‒ </span>He votado a favor del informe sobre la propuesta de Reglamento del Parlamento Europeo y del Consejo sobre los medicamentos veterinarios.</p>
<p class="contents">Los medicamentos veterinarios se encuentran regulados en la Directiva 2001/82/CE y en el Reglamento (CE) n.º 726/2004. En el año 2004, la Comisión propuso unir ambos actos, con objetivos como la mejora del acceso a los medicamentos veterinarios, la reducción de la carga burocrática, el análisis de la resistencia a los antibióticos y la promoción de la innovación. </p>
<p class="contents">La cuestión relativa a los medicamentos veterinarios, así como la necesidad de establecer un enfoque global en relación con su uso, hace que sea obligatoria la revisión de la legislación farmacéutica veterinaria. Por ello, el Grupo socialista exige la inclusión de unos objetivos más ambiciosos, como la prohibición del uso de profilácticos en los antibióticos o la clarificación de las condiciones por las cuales los veterinarios prescriben y venden antibióticos, así como la venta en línea de los mismos. Se debe endurecer el marco de los medicamentos humanos para su uso con animales y establecer una serie de medidas preventivas antes de recurrir a tratamientos antimicrobianos de grupos enteros de animales que se encuentran destinados a la producción de alimentos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-239-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96681.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Vilija Blinkevičiūtė (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau dėl šio pranešimo, kuriuo siekiama priimti Europos Parlamento ir Tarybos reglamentą dėl veterinarinių vaistų. Šiuo reglamento projektu siekiama reglamentuoti veterinarinių vaistų leidimų suteikimą, gamybą, rinkodarą, veterinarinių vaistų platinimą ir naudojimą visu jų galiojimo laikotarpiu, taip pat jiems taikomą farmakologinio budrumo procesą. Padaryta išvada, kad reikia nustatyti specialią reglamentavimo sistemą, pritaikytą prie veterinarijos sektoriaus ypatumų. Taikant dabar galiojančią teisinę sistemą kilo problemų, pavyzdžiui, susijusių su veterinarinių vaistų trūkumu (ypač mažose rinkose), reglamentavimo lemiama administracine našta, vidaus rinkos veikimu ir, žinoma, atsparumo antibiotikams reiškiniu. Komisija norėtų sudaryti labai svarbių antibiotikų, skirtų tik žmonėms gydyti, sąrašą. Europos Parlamentas pritaria šiai idėjai, jei tik šis sąrašas būtų pagrįstas tvirtais moksliniais kriterijais. Europos vaistų agentūra šiuo klausimu pateikė puikių rekomendacijų, kurių reikėtų laikytis. Galiausiai, priešingai negu siūlo Komisija, antibiotikų (ir apskritai receptinių veterinarinių produktų) prekybą internetu reikėtų uždrausti, nes ji kelia didelį pavojų visuomenės sveikatai. Komisija taip pat siūlo supaprastinti žmonėms skirtų be rinkodaros leidimo parduodamų vaistų naudojimą gyvūnams gydyti. Tekste atsakomybė spręsti dėl tokio naudojimo paliekama veterinarijos gydytojams. Parlamentas nekvestionuoja veterinarijos gydytojų atsakomybės, tačiau ragina geriau apibrėžti šią galimybę patikslindamas, kad žmonėms skirtų vaistų naudojimo galima imtis tik kaip kraštutinės priemonės, kai nėra jokių geresnių alternatyvų.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-239-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124814.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Simona Bonafè (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Accolgo con favore la relazione votata oggi, che segna un importante passo in avanti nella lotta per contrastare la resistenza antibiotica, attraverso un utilizzo più limitato e responsabile dei farmaci antimicrobici esistenti e lo sviluppo di nuovi medicinali. </p>
<p class="contents">Il testo mira ad aggiornare la normativa europea in materia di medicinali veterinari, escludendo pratiche di trattamento antibiotico a scopo meramente preventivo o di tipo collettivo, incoraggiando invece la ricerca e la creazione di nuovi farmaci di qualità. Ridurre l'utilizzo, senza specifica autorizzazione, dei farmaci antibiotici non significa però smantellare la nostra dotazione di medicinali veterinari; il nuovo regolamento mira, anzi, a facilitare l'accesso a tali farmaci all'interno dell'Unione, creando condizioni più favorevoli alla loro circolazione grazie anche a migliori procedure di autorizzazione, una farmacovigilanza più efficace e minori oneri amministrativi. </p>
<p class="contents">Si incentiva così un uso più meditato e regolamentato dei farmaci, che non possono sostituirsi in nessun caso a buone pratiche di allevamento e devono essere somministrati solo dopo un'accorta valutazione da parte del veterinario, potenziando, conseguentemente, le tutele a favore della salute animale, umana e dell'ambiente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-239-0562"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112748.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Biljana Borzan (S&amp;D), </span></span>  <span class="italic">napisan. ‒ </span>Ova regulativa uređuje odnose u distribuciji i upotrebi veterinarskih lijekova, no moj glavni fokus je bio na onim dijelovima koji se bave suzbijanjem antimikrobijalne otpornosti.Važno je da regulativa sadrži odredbu o zabrani određenih antibiotika u veterini kako bi se sačuvali za ljudsku upotrebu. No, da bi to imalo smisla ona mora biti retroaktivna, dakle uključivati obvezu povlačenja s tržišta onih rezerviranih antibiotika koji su već u prodaji. </p>
<p class="contents">Nadalje, ključno je vezivanje distribucije antibiotika uz recept izdan od odgovorne osobe. Isto tako, kako bi se spriječile moguće zloupotrebe u interesu javnog zdravlja je da se zabrani online prodaja antibiotika. Zaključno, smatram da je prijedlog regulative koji izlazi iz Parlamenta dobro osmišljen i da će pridonijeti boljoj zaštiti životinjskog i ljudskog zdravlja. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-239-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124787.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Renata Briano (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>La disposizione è utile per migliorare l'accesso ai prodotti medico-sanitari, in particolare nel settore veterinario in cui si registra una penuria di farmaci in molti ambiti di mercato. </p>
<p class="contents">Gli obbiettivi principali della disposizione sono riassumibili nella volontà di migliorare l'accesso ai farmaci e la loro disponibilità, segnatamente per le specie dette impropriamente "minori"; di ridurre gli oneri amministrativi, in particolare per quanto concerne il processo di farmacovigilanza; di stimolare l'innovazione e la competitività del settore; di garantire il buon funzionamento del mercato interno per i farmaci veterinari; oltre a combattere la resistenza agli antibiotici che rappresenta un elemento di pericolosità, sia per la salute umana che per quella degli animali, di rilevanza crescente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-239-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125012.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Daniel Buda (PPE), </span></span>  <span class="italic">în scris. ‒ </span>Sectorul creșterii animalelor reprezintă 41 % din totalul investițiilor în agricultură, cu un total de peste 12 milioane de animale cu o valoare de 142 miliarde EUR. Armonizarea condițiilor pentru prescripțiile veterinare, recunoașterea acestora la nivelul statelor membre, precum și autorizarea altor persoane calificate să elibereze anumite prescripții contribuie semnificativ la reducerea birocrației și la utilizarea rațională a medicamentelor veterinare. De asemenea, ținând cont de evoluțiile tehnologice, utilizarea prescripțiilor electronice facilitează activitatea fermierilor.</p>
<p class="contents">Avem în vedere faptul că rezistența antimicrobiană reprezintă un factor de risc major asupra sănătății și bunăstării animalelor, iar efectele se resimt în mod direct asupra sănătății umane. Interzicerea utilizării antibioticelor în tratamentele profilactice contribuie semnificativ la reducerea volumului de medicamente administrat animalelor. Sunt de părere că prevenția este de cele mai multe ori mai eficientă, iar costurile mai reduse, cantitatea de medicamente utilizată în tratamentul preventiv fiind mult mai redusă în comparație cu cea utilizată în tratamentele metafilactice.</p>
<p class="contents">Propunerea de regulament privind medicamentele de uz veterinar trebuie adaptată realităților de pe teren, trebuie să urmărească reducerea sarcinilor administrative, ținând cont de nevoile fermierilor și să răspundă cerințelor consumatorilor. Sunt de părere că votul în Comisia ENVI a constituit garanția necesară pentru ca acest raport să intre în negocierile interinstituționale.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124869.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gianluca Buonanno (ENF), </span></span>  <span class="italic">per iscritto. ‒ </span>Voto contrario. Con questo nuovo regolamento, la normativa per l'autorizzazione e l'immissione sul mercato dei medicinali per uso veterinario viene separata da quella per uso umano. Ciò apporta indubbiamente maggiore chiarezza. Tuttavia, nel merito, il voto finale non può essere favorevole per queste ragioni essenziali: non è scongiurata del tutto l'immissione nella catena alimentare degli animali su cui sono state effettuate sperimentazioni cliniche; sono ammessi medicinali contenenti OGM (gli em. 297 e 131 tendono invece a vietarli); sono abilitati alla prescrizione veterinaria anche altri soggetti diversi dai veterinari; è ammessa la vendita online anche dei medicinali soggetti a prescrizione; insufficienti misure di contrasto alla resistenza antimicrobica (benché migliorate dagli emendamenti).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0062"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/38420.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cristian-Silviu Buşoi (PPE), </span></span>  <span class="italic">în scris. ‒ </span>Impactul medicamentelor de uz veterinar asupra sănătății atât a animalelor, cât și a oamenilor este unul foarte îngrijorător. Utilizarea medicamentelor este strâns legată de rezistența antimicrobiană dezvoltată la animale, iar, prin consumul de produse lactate sau de carne care își au originea în respectivele animale, rezistența se transferă și la oameni. Principala cauză constă în administrarea profilactică a medicamentelor antimicrobiene la animale, utilizate uneori pentru a îmbunătăți performanța sau a compensa dezvoltarea necorespunzătoare a acestora. Prin acest raport, dorim limitarea utilizării profilactice a antibioticelor numai în situațiile justificate de medicul veterinar prin prezența unor simptome clinice clare. Combaterea rezistenței la antimicrobiene reprezintă o prioritate pentru UE, deoarece vizează îmbunătățirea siguranței pacienților, iar raportul doamnei Grossetête vine să sublinieze rolul Uniunii în crearea unui singur plan de acțiune pentru combaterea rezistenței la antimicrobiene.</p>
<p class="contents">Pe de altă parte, acest raport urmărește crearea unui cadru de stimulare și de susținere a inovării în ceea ce privește medicamentele de uz veterinar, pentru a nu reduce arsenalul terapeutic al veterinarilor. Industria are nevoie de încurajare pentru crearea de noi medicamente și introducerea lor pe piața medicamentelor de uz veterinar, întrucât aceasta este relativ mică și fragmentată.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125041.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Soledad Cabezón Ruiz (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establezca la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96849.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alain Cadec (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Le présent rapport a pour objectif de simplifier la législation sur les médicaments vétérinaires en fusionnant la directive instituant un code communautaire relatif aux médicaments vétérinaires avec le règlement qui établit des procédures communautaires pour l'autorisation et la surveillance des médicaments à usage humain et vétérinaire. </p>
<p class="contents">Ce nouveau texte permettra de lutter contre les abus d'utilisation d'antibiotiques dans l'élevage. La vente et la prescription d'antibiotiques à usage vétérinaire seront fortement réduites et plus encadrées. Il est nécessaire de mettre en place une législation adaptée au nouveau phénomène de résistance aux antibiotiques. En effet, la quantité d'antibiotiques que nous consommons via notre alimentation provoque une certaine accoutumance qui rend ces antibiotiques moins efficaces pour nous soigner quand nous sommes malades. </p>
<p class="contents">J'ai voté pour ce texte qui constitue la position du Parlement européen pour les négociations avec les États membres. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124851.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicola Caputo (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Oggi ho votato a favore della proposta di regolamento in questione, che imposta un quadro normativo appositamente concepito per le caratteristiche del settore veterinario. Il quadro giuridico in vigore è stato fonte di problemi in sede di applicazione, in particolare per quanto riguarda la penuria di medicinali veterinari, il funzionamento del mercato interno, il fenomeno della resistenza agli antibiotici, la mancanza di incentivi volti a sostenere l'innovazione, e gli oneri amministrativi imposti. La proposta approvata oggi pone rimedio a tutte queste lacune.</p>
<p class="contents">La questione della resistenza agli antibiotici sta dicendo una cosa sempre più preoccupante: ogni anno un consumatore medio di carne ingerisce a sua insaputa quasi 9 grammi di antibiotici (l'equivalente di quattro cure). </p>
<p class="contents">Bisogna quindi promuovere maggiormente l'uso responsabile nei medicinali veterinari degli antibiotici che sono importanti per la medicina umana, come ad esempio i "fluorochinoloni" e le "cefalosporine". L'uso diffuso di queste due sostanze in allevamento per contrastare contagi comuni contribuisce alla diffusione della resistenza antimicrobica. Penso che, laddove non sia stata diagnosticata alcuna malattia, debba essere vietata la somministrazione di antimicrobici a scopo preventivo o profilattico.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0281"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124986.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Matt Carthy (GUE/NGL), </span></span>  <span class="italic">in writing. ‒ </span>This report sets out a new legal framework for veterinary medicines for authorisation, manufacturing, drug safety and their use. The aim of the report is to strengthen the Commission proposal. This report calls for the ban on prophylactic use of veterinary medicines which contain antimicrobials (albeit with some exceptions) which is an important move forward in combatting antimicrobial resistance. Therefore, I voted in favour of this report.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0312"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124971.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">James Carver (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0343"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28122.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">David Casa (PPE), </span></span>  <span class="italic">in writing. ‒ </span>This is a very good report that includes excellent amendments to Directive 2001/82/EC, for example in relation to access to medicinal products, innovation and environmental protection. However, I believe that this report is not yet mature for agreement and I agree with the need to postpone the final vote in order to fine-tune the details.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0359"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124812.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Fabio Massimo Castaldo (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>Mentre l'obiettivo fondamentale dell'industria è di realizzare un mercato unico per i medicinali veterinari, l'obiettivo principale del M5S Europa è la salvaguardia del benessere animale, l'aumento delle disponibilità di medicinali veterinari in tutta Europa e soprattutto il passaggio da una cultura di cura di massa degli animali a una cultura in cui agli animali vengono somministrate cure individuali come agli uomini. Ho quindi votato a favore.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0367"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96603.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nessa Childers (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I welcome today’s vote in the European Parliament to usher in tighter controls and restrictions on the administration of antibiotics to farm animals.</p>
<p class="contents">We cannot allow cost-cutting business as usual to carry on in large-scale, industrial farming. Increased resistance to the most common antibiotics could bring us back to the dark ages of medicine, when we were at the mercy of infectious diseases and the chances of surviving surgery were scant.</p>
<p class="contents">This is not an overstatement. The World Health Organisation has been compiling alarming data on the development of multi-drug resistant superbugs that pose severe public health risks on a global scale.</p>
<p class="contents">I am glad we managed to bring a majority of MEPs on board to make progress on this critical issue. We cannot afford to allow the indiscriminate use of antibiotics, which are often sold online and end up on our plates.</p>
<p class="contents">These heightened threats to human health and life make the use of medication to make up for shoddy animal husbandry absolutely unacceptable. We certainly need to establish classes of antimicrobials which are critical for human treatment and must be off-limits for other purposes.</p>
<p class="contents">I very much hope that the Member States’ governments will be similarly minded, and refrain from diluting the agreement we reached today.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/26837.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λευτέρης Χριστοφόρου (PPE), </span></span>  <span class="italic">γραπτώς. ‒ </span>Στηρίζουμε την έκθεση που αφορά την αδειοδότηση, κατασκευή, εμπορία, διανομή, την ασφάλεια των φαρμάκων και τη χρήση των κτηνιατρικών φαρμακευτικών προϊόντων.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124988.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Deirdre Clune (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I supported this vote because it will help prevent the misuse and overuse of antibiotics on animals which could then potentially enter the human supply chain. The report covers, amongst other things: routine prophylactic use of antimicrobials being banned and metaphylactic use restricted; and the data protection period of technical documentation for new antibiotics set at 14 years with the possibility of prolongation however limited. Online sale of antimicrobials, psychotropics and vaccines is not allowed. It will also result in harmonisation of the requirement for a veterinary prescription and recognition of prescriptions across Member States.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0468"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124967.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">David Coburn (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-240-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1892.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Carlos Coelho (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>A Comissão Europeia apresentou a proposta de regulamento relativa aos medicamentos veterinários que incorpora uma reformulação total da legislação relativa aos medicamentos veterinários, até aqui enquadrada pela Diretiva 2001/82/CE e pelo Regulamento (CE) n.º 726/2004, com o objetivo de regulamentar a autorização, o fabrico, a introdução no mercado, a distribuição e a utilização dos medicamentos veterinários ao longo de todo o seu ciclo de vida, assim como o processo de farmacovigilância aplicável.</p>
<p class="contents">Apoio o Relatório Grossetête, por considerar que se impunha a criação de um quadro regulamentar específico, adaptado às características do setor veterinário, desde logo tendo em conta os problemas que surgiram com a aplicação do quadro jurídico em vigor, nomeadamente a falta de disponibilidade de medicamentos veterinários, os encargos administrativos impostos pela regulamentação, o funcionamento do mercado interno e, claro, o fenómeno cada vez mais preocupante da resistência aos antibióticos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112788.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Birgit Collin-Langen (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich habe für den Bericht gestimmt, denn ich unterstütze den Ansatz, dass der Markt für Tierarzneimittel vom Markt für Humanarzneimittel deutlich zu trennen ist. Ich begrüße, dass der Zugang und die Verfügbarkeit von Arzneimitteln wie auch die Förderung des Binnenmarkts für Tierarzneimittel erleichtert werden. Voraussetzung hierfür ist die bessere Zusammenarbeit innerhalb der 28 EU-Mitgliedstaaten, womit wir auch einen besseren grenzüberschreitenden Verbraucherschutz gewährleisten werden können. Ich unterstütze auch den ambitionierteren Ansatz der Berichterstatterin, wonach es keinen präventiven Einsatz von Antibiotika in der Tieraufzucht mehr geben soll. Dere ist dringend notwendig, damit wir Antibiotikaresistenzen bekämpfen können.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124955.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jane Collins (EFDD),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96775.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lara Comi (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Il quadro giuridico del settore veterinario è da sempre stato fonte di problemi in sede di applicazione, in particolare per quanto riguarda la penuria di medicinali veterinari (soprattutto per i mercati più piccoli), gli oneri amministrativi imposti, il funzionamento del mercato interno e, naturalmente, il fenomeno della resistenza agli antibiotici. </p>
<p class="contents">Per questi motivi, la proposta della Commissione getta le basi per una completa rifusione della legislazione relativa ai medicinali veterinari, attualmente fondata sulla direttiva 2001/82/CE e sul regolamento (CE) n. 726/2004, ed è destinata a disciplinare l'autorizzazione, la fabbricazione, l'immissione in commercio, la distribuzione e l'impiego dei medicinali veterinari durante l'intero ciclo di vita, nonché il relativo processo di farmacovigilanza. Ritengo che essa vada fondamentalmente nella buona direzione, sia negli obiettivi che nella volontà di operare una netta distinzione tra il mercato dei medicinali veterinari e quello dei medicinali per uso umano. Concordo con i commenti e le modifiche della relatrice e per questo motivo ho votato favorevolmente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124968.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Therese Comodini Cachia (PPE), </span></span>  <span class="italic">in writing. ‒ </span>There is a need for new legislation which should increase the scope for research into and development and monitoring of veterinary medicinal products and which will increase production and profitability on the internal market. There is also a growing need for new and better medicines for use in livestock farming, in view of climate change and the worldwide trend towards greater movement. From the farmers’ point of view, it is of decisive importance that effective and accessible medicines should be available at a reasonable price when they are needed.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124856.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ignazio Corrao (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>La Commissione ha richiesto di stabilire norme in materia di medicinali veterinari, dal momento della fabbricazione all'immissione sul mercato, comprendendo il momento dell'importazione, dell'esportazione e del controllo, per perseguire l'obiettivo di migliorare il funzionamento del mercato interno, ridurre gli oneri amministrativi, stimolare la competitività e l'innovazione ed aumentare la disponibilità dei medicinali veterinari. </p>
<p class="contents">Il quadro normativo europeo riguardo ai medicinali veterinari deve essere adeguato al progresso scientifico e deve tutelare l'animale, cercando di ridurre al minimo le sofferenze di questo e assicurandone il benessere. Poiché molte nostre richieste sono state accettate e reputo tale tema di importanza rilevante, mi esprimo favorevolmente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125997.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Javier Couso Permuy (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor del presente informe porque considero que, pese a que discrepo en importantes puntos, supone una mejora de la legislación en este ámbito en un momento de vigente necesidad. El informe incluye referencias muy positivas al papel exclusivo que deben desempeñar los veterinarios en la prescripción de este tipo de medicamentos; igualmente el informe se refiere positivamente a la necesidad de evaluar el impacto ambiental de los medicamentos en el medio ambiente, la inclusión de las pequeñas y medianas empresas, la prevención de sufrimientos innecesarios en los animales, etc. Este Reglamento resulta muy necesario frente a las crisis que está sufriendo el sector ganadero, con elementos como la extensión de la tuberculosis entre otras enfermedades que necesitan la disponibilidad de este tipo de medicamentos veterinarios. Es por todo esto por lo que he decidido votar a favor del presente informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-241-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/40224.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andi Cristea (S&amp;D), </span></span>  <span class="italic">în scris. ‒ </span>Acest regulament vizează să reglementeze autorizarea, fabricarea, comercializarea, distribuirea și utilizarea medicamentelor de uz veterinar de-a lungul ciclului lor de viață, precum și procesul de farmacovigilență aferent. Prezentul act legislativ este mai ambițios în ceea ce privește dispozițiile legate de combaterea rezistenței la antibiotice, vine în special cu definiții clare ale diferitelor forme de tratament (tratament curativ, tratament de control și tratament preventiv) și interzice utilizarea profilactică a medicamentelor antibacteriene. Astfel, este esențială o coerență strânsă între Regulamentul privind furajele medicamentate și Regulamentul privind medicamentele de uz veterinar.</p>
<p class="contents">Crearea unei liste a antibioticelor importante, rezervate medicinei umane, pe care Comisia dorește s-o realizeze, ar trebui făcută doar cu condiția ca aceasta să fie bazată pe criterii științifice solide. De asemenea, vânzarea pe internet de antibiotice (și, în sens mai general, vânzarea de medicamente de uz veterinar pentru care este necesară prescripție) trebuie interzisă, deoarece prezintă un risc grav pentru sănătatea publică.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-242-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/132925.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Edward Czesak (ECR), </span></span>  <span class="italic">na piśmie. ‒ </span>We wrześniu 2014 r. Komisja opublikowała nowy projekt rozporządzenia w sprawie weterynaryjnych produktów leczniczych. Projekt ten całkowicie restrukturyzuje dotychczasowe przepisy odnoszące się do weterynaryjnych produktów leczniczych. Ma uregulować wydawanie pozwoleń, wytwarzanie, wprowadzanie do obrotu, dystrybucję, nadzór nad bezpieczeństwem farmakoterapii i stosowanie weterynaryjnych produktów leczniczych. </p>
<p class="contents">Udało się wypracować wiele narzędzi oraz działań, m.in. gromadzenie przez państwa członkowskie danych o stosowaniu środków przeciwdrobnoustrojowych, sporządzenie wykazu środków przeciwdrobnoustrojowych, które mają być zarezerwowane do leczenia niektórych zakażeń u ludzi, z myślą o zachowaniu skuteczności określonych substancji czynnych u ludzi, zakazanie rutynowego stosowania środków przeciwdrobnoustrojowych w profilaktyce oraz surowe warunki profilaktyki <span class="italic">ad hoc</span> i metafilaktyki oraz minimalne wymogi w zakresie recepty weterynaryjnej, jak i wprowadzenie szeregu kategorii weterynaryjnych produktów leczniczych (posiadających właściwości anaboliczne, przeciwzapalne, przeciwzakaźne (inne niż przeciw robakom), przeciwrakowe, hormonalne lub psychotropowe lub zawierających takie substancje), na które receptę może wystawić wyłącznie lekarz weterynarii. Poparłem w głosowaniu przedmiotowy dokument.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-243-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124970.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miriam Dalli (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of this regulation on veterinary medicinal products that will govern the authorisation, manufacturing, marketing, distribution, drug safety and use of veterinary medicinal products over their lifetime. This regulation aims to improve access to medicinal products and make them widely available, to reduce the administrative burden, to promote innovation and competitiveness within the sector, to ensure that the internal market for veterinary medicinal products functions properly, and to tackle antibiotic resistance.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/35135.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Daniel Dalton (ECR), </span></span>  <span class="italic">in writing. ‒ </span>I support the creation of a more streamlined system of regulation of veterinary medicines allowing for improvements in the treatment of animal diseases. This reduction of bureaucracy in the industry is an important tool in assisting the development and production of medicines and treatment and safeguarding animals. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97296.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Michel Dantin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Ce rapport législatif a pour objectif de réviser la législation en matière de médicaments vétérinaires, datant de 2004. Le texte couvre l'autorisation, la production, la vente, la distribution et l'utilisation des médicaments vétérinaires pendant leur durée de vie. </p>
<p class="contents">Il vise notamment à améliorer l'accès aux produits médicaux pour les professionnels et à encourager l'innovation. L'harmonisation des conditions de prescription vétérinaire et la reconnaissance mutuelle entre les États membres permettra de créer des conditions équitables entre les pays et un niveau minimum de sécurité sanitaire. Le texte prévoit également de faciliter la circulation des médicaments vétérinaires à travers l'Union, tout en réduisant l'usage des antibiotiques dans l'élevage. </p>
<p class="contents">Considérant que ce rapport facilite l'accès sécurisé des médicaments vétérinaires via l'achat en ligne pour les éleveurs et leur prescription par les vétérinaires, j'ai voté en faveur de ce rapport.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124803.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Isabella De Monte (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Nel settembre 2014, la Commissione ha reso pubblica la nuova proposta di regolamento in materia di medicinali veterinari. Quest'ultima getta le basi per una completa rifusione della legislazione relativa ai medicinali veterinari ed è destinata a disciplinarne l'autorizzazione, la fabbricazione, l'immissione in commercio, la distribuzione e l'impiego durante l'intero ciclo di vita. </p>
<p class="contents">Tra gli obiettivi individuati dalla Commissione, merita porre l'accento sulla lotta contro la resistenza agli antibiotici e la promozione dell'innovazione e della competitività del settore. Ho votato a favore di questa relazione poiché ritengo sia importante operare una netta distinzione tra il mercato dei medicinali veterinari e quello dei medicinali per uso umano, garantendo la disponibilità dei prodotti e promuovendo la semplificazione amministrativa, senza rinunciare agli obiettivi imprescindibili della salute pubblica e della tutela dell'ambiente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124732.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Angélique Delahaye (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>L'antibiorésistance est aujourd'hui un véritable fléau de santé publique qui trouve sa source dans l'abus d'antibiotiques dans les élevages. C'est pourquoi j'ai voté en faveur de ce règlement qui vise à réviser entièrement le cadre législatif applicable aux médicaments vétérinaires.</p>
<p class="contents">Ainsi, le texte promulgue un certain nombre de dispositions visant à encadrer l'usage de ces substances en médecine vétérinaire, et cela afin de réduire le nombre d'antibiotiques qui se retrouvent dans l'assiette du consommateur. </p>
<p class="contents">À travers ce vote, nous avons pour ambition d'encourager et de protéger l'innovation, de réduire la bureaucratie et d'assouplir certaines procédures de mise sur le marché.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/117477.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mark Demesmaeker (ECR), </span></span>  <span class="italic">schriftelijk. ‒ </span>De toenemende resistentie tegen menselijke en dierlijke antibiotica vormt een torenhoog probleem voor de volksgezondheid. In 2050 zouden naar schatting wereldwijd jaarlijks tien miljoen mensen sterven aan de gevolgen van resistente bacteriën, door een overmatig en verkeerd gebruik van antibiotica. De waarschuwingen van zowel de Wereldgezondheidsorganisatie als het Europees Centrum voor Ziektepreventie en Controle (ECDC) zijn welbekend. Als we willen vermijden dat antibiotica onbruikbaar worden zijn maatregelen op verschillende niveaus noodzakelijk.</p>
<p class="contents">De actualisering van de wetgeving voor geneesmiddelen voor diergeneeskundig gebruik die het Europees Parlement vandaag goedkeurde, geeft een sterk signaal terzake dat de N-VA-delegatie steunt: om antimicrobiële resistentie drastisch te verminderen moet het preventief gebruik van antibiotica bij dieren aan banden worden gelegd. Tegelijk moeten innovatie, onderzoek en competitiviteit voluit worden gestimuleerd om de beschikbaarheid van geneesmiddelen te verhogen en moeten administratieve lasten worden verminderd.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/94282.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-Paul Denanot (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai soutenu ce rapport dont l'objet est de lutter contre la résistance croissante des bactéries aux antibiotiques actuels. Ce vote intervient à l'occasion du projet de mise à jour de la législation de l'Union relative aux médicaments vétérinaires. </p>
<p class="contents">Nous prônons une utilisation limitée des antimicrobiens existants (en interdisant notamment le traitement antibiotique collectif et préventif des animaux; les médicaments vétérinaires ne doivent en aucun cas être utilisés pour améliorer les performances des élevages ou pour compenser le non-respect de bonnes pratiques d'élevage) et nous demandons l'élaboration de nouveaux produits moins nocifs pour la santé humaine. </p>
<p class="contents">À ce titre, je souhaite qu'une attention particulière soit portée à la vente en ligne d'antibiotiques, de vaccins et de produits psychotropes. Il faut absolument mettre un terme à cette possibilité d'achat non contrôlé.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124873.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ангел Джамбазки (ECR), </span></span>  <span class="italic">в писмена форма. ‒ </span>Подкрепих доклада, защото смятам, че ограничаването на употребата на антибиотици в селското стопанство е наложително. Мерки трябва да бъдат взети, защото здравето на гражданите за мен е водещо. Това, разбира се, трябва да стане постепенно, като не може да бъде напълно забранено и то изведнъж, защото разпространяването на болести в тази област също може да бъде застрашено. </p>
<p class="contents">Използването на антимикробни лекарства е прекрасна алтернатива и техните производители и изследователи трябва да бъдат стимулирани. Радвам се, че този доклад предоставя такива стимули, като например удължаване на периода на защита за техническата документация на новите лекарства.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125071.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Γεώργιος Επιτήδειος (</span></span>  <span class="bold">NI</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Θετικά, αν περάσει η πλειοψηφία των τροπολογιών των Πρασίνων ή αν δεν περάσουν οι τροπολογίες του PPΕ, διότι είναι ένα κείμενο πάρα πολύ σημαντικό για τη δημόσια υγεία.</p>
<p class="contents">Αρνητικά, μόνο σε περίπτωση που δεν περάσουν οι τροπολογίες των Πρασίνων και περάσουν του PPΕ.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124711.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Norbert Erdős (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet ezidáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A Környezetvédelmi Bizottság által jóváhagyott szöveg kiemelten kezeli az állatgyógyászati készítmények elérhetőségének problémáját, amelyre az innováció megerősítése nyújthat megoldást. Az állatgyógyászati készítmények piaca ugyanis kicsi és rendkívül széttagolt, az ágazati szereplők így csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés kiemelten kezeli a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott trilógusokhoz. Jó lépés a megfelelő irányba.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0843"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96899.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Manuel Fernandes (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>A proposta visa melhorar a disponibilidade dos medicamentos veterinários, reduzir os encargos administrativos, estimular a inovação no setor e lutar contra a resistência aos antibióticos.</p>
<p class="contents">Os medicamentos veterinários antimicrobianos não devem, em circunstância alguma, ser utilizados para melhorar os níveis de produção ou para compensar a inobservância de boas práticas de criação de animais. A luta contra a resistência aos antibióticos deve começar nos locais de criação de animais.</p>
<p class="contents">Pretende-se com a proposta, em especial, proibir a utilização puramente preventiva dos antibióticos, restringir os tratamentos em massa a casos bem específicos, proibir a utilização veterinária de antibióticos de importância crítica para a medicina humana e pôr fim à venda através da Internet de medicamentos antimicrobianos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124767.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Edouard Ferrand (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté contre: même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelle sanitaire.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-244-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96706.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">João Ferreira (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Este relatório contém aspetos positivos. Garantir a produção de medicamentos veterinários seguros, eficazes e acessíveis constitui um objetivo importante para os nossos produtores. A introdução da questão dos medicamentos genéricos, das resistências antimicrobianas ou dos pequenos mercados são elementos importantes que vão no sentido correto.</p>
<p class="contents">No entanto, é evidente a pressão exercida pelas empresas multinacionais sobre as instituições da UE, pretendendo alargar ao máximo os seus privilégios e proveitos.</p>
<p class="contents">Era necessário ir mais longe na salvaguarda dos interesses dos países mais pequenos, de forma a evitar que as multinacionais disponibilizem os seus produtos apenas nos mercados mais rentáveis.</p>
<p class="contents">A proposta da Comissão Europeia defende o interesse das multinacionais farmacêuticas, propondo o prolongamento dos períodos de proteção da documentação no que diz respeito aos antibióticos (18 anos em vez de 14) e a inclusão de espécies principais no âmbito da autorização de introdução no mercado (dois anos suplementares em vez de um).</p>
<p class="contents">Além disso, prevê a possibilidade de instaurar um período de proteção de 5 anos (não cumulativos) para certos estudos ou ensaios novos pós-autorização.</p>
<p class="contents">Apresentámos propostas de alteração, de modo a baixar estes períodos de proteção de documentos, de modo a que seja possível às empresas de genéricos e às pequenas e médias empresas aceder e entrar no mercado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23868.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Flašíková Beňová (S&amp;D), </span></span>  <span class="italic">písomne ‒ </span>Európska únia si už dlho udržuje vysoké štandardy v oblasti ochrany verejného zdravia a životného prostredia. Vítam návrh Európskej komisie, pretože ním sleduje dôkladné oddelenie veterinárnych liekov od humánnych liekov. Európska komisia týmto nariadením sleduje najmä zlepšenie prístupu k liekom a ich dostupnosť pre rôzne druhy zvierat, obmedzenie administratívnej záťaže, ale aj zlepšenie fungovania vnútorného trhu s veterinárnymi liekmi. Podľa viacerých expertov a poslancov Európskeho parlamentu mohla Európska komisia prijať ešte ambicióznejšie nariadenie a mala by v budúcnosti odstrániť viaceré nedostatky napríklad boja proti odolnosti voči antimikrobiálnym liekom alebo ochrane životného prostredia zavedením jednotného decentralizovaného hodnotenia.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125070.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λάμπρος Φουντούλης (</span></span>  <span class="bold">NI</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Υπερψηφίζω την έκθεση σχετικά με την πρόταση κανονισμού του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου για τα κτηνιατρικά φάρμακα. Σε κάθε περίπτωση, για λόγους δημόσιας υγείας ο νέος κανονισμός θα πρέπει να δίνει τη δυνατότητα στα κράτη μέλη να διατηρήσουν ή να εγκρίνουν μεγαλύτερης εμβέλειας κανόνες σχετικά με τη χρήση και τη συνταγογράφηση αντιμικροβιακών φαρμάκων. Για την υγειονομική και περιβαλλοντική ασφάλεια πρέπει να χρησιμοποιούνται κατά προτεραιότητα τα επιτρεπόμενα κτηνιατρικά φάρμακα. Η χρήση φαρμάκων που προορίζονται για ανθρώπινη χρήση πρέπει να υπόκειται σε αυστηρούς όρους.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124790.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Doru-Claudian Frunzulică (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I would like to endorse the proposal and to welcome the alignment with the Lisbon Treaty. I support the decoupling of marketing authorisations for veterinary medicinal products from those for human medicinal products, to take account of the specific needs of the veterinary sector.</p>
<p class="contents">It is important to harmonise the requirements for a veterinary prescription and recognition of prescriptions across Member States; to stimulate innovation and the development of new veterinary medicines; and to harmonise the periods of protection (and potential prolongation) of new data packages related to antimicrobial veterinary medicinal products.</p>
<p class="contents">I believe the regulation will provide better access to veterinary medicines, take measures to fight antimicrobial resistance, reduce the administrative burden, and promote innovation and competitiveness within the sector.</p>
<p class="contents">Finally I support action to reduce the use of antibiotics, which may not be sold via the internet.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28150.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kinga Gál (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet ezidáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A Környezetvédelmi Bizottság által jóváhagyott szöveg kiemelten kezeli az állatgyógyászati készítmények elérhetőségének problémáját, amelyre az innováció megerősítése nyújthat megoldást. Az állatgyógyászati készítmények piaca ugyanis kicsi és rendkívül széttagolt, az ágazati szereplők így csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés kiemelten kezeli a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott trilógusokhoz. Jó lépés a megfelelő irányba.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0222"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28298.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Iratxe García Pérez (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establece la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0226"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96991.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Eider Gardiazabal Rubial (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establece la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0230"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124807.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jens Gieseke (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Im Tierarzneimittelbereich besteht ein großer Bedarf an neuen Rechtsvorschriften. Ein von mir und einigen Kollegen eingebrachter Änderungsantrag trägt dazu bei, überflüssige Bürokratie zu vermeiden. Naturprodukte und somit klassische Alternativen zum Antibiotikaeinsatz konnten aus der Regelung herausgenommen werden.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0234"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124965.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nathan Gill (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines including antibiotics should be used responsibly, under veterinary care and according to licensing conditions. We believe that the British Parliament should be able to legislate on this issue without being overruled by the unelected EU Commission.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0238"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/127330.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tania González Peñas (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Hemos votado A FAVOR de este informe dado que apunta a un mayor control tanto del ciclo de venta de los antibióticos como del uso de los mismos. Limita la venta en internet de medicinas que deberían venderse con prescripción médica, se limita y controla el uso de forma preventiva y se refiere a otras cuestiones que atañen a criterios de bienestar animal. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0242"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124763.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Antanas Guoga (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the report. There is a need to ensure the availability of safe, effective and affordable veterinary medicinal products in the EU while guaranteeing their responsible use.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/103488.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sergio Gutiérrez Prieto (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establece la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23816.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">András Gyürk (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet ezidáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A Környezetvédelmi Bizottság által jóváhagyott szöveg kiemelten kezeli az állatgyógyászati készítmények elérhetőségének problémáját, amelyre az innováció ösztönzése nyújthat megoldást. Az állatgyógyászati készítmények piaca ugyanis kicsi és rendkívül széttagolt, az ágazati szereplők csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés előtérbe helyezi a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott trilógusokhoz.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96907.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Τάκης Χατζηγεωργίου (</span></span>  <span class="bold">GUE</span><span class="bold">/</span><span class="bold">NGL</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Με την πάροδο του χρόνου έχει καταστεί σαφές ότι οι ανάγκες του κτηνιατρικού τομέα διαφέρουν σημαντικά από εκείνες του ανθρώπινου τομέα σε σχέση με τα φάρμακα. Για παράδειγμα, οι μηχανισμοί καθορισμού των τιμών στον κτηνιατρικό τομέα ακολουθούν μια εντελώς διαφορετική λογική. Ως εκ τούτου, οι τιμές για τα κτηνιατρικά φάρμακα είναι συνήθως σημαντικά χαμηλότερες από ό,τι για τα φάρμακα που προορίζονται για ανθρώπινη χρήση. Υπερψηφίσαμε την έκθεση, αφού προτείνει μέτρα αντιμετώπισης τέτοιων προβλημάτων όπως (α) την έλλειψη διαθεσιμότητας των κτηνιατρικών φαρμακευτικών προϊόντων, (β) διοικητικές επιβαρύνσεις, (γ) μείωση της ανταγωνιστικότητας και της καινοτομίας και (δ) τον κίνδυνο για τη δημόσια υγεία της μικροβιακής αντοχής (AMR).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-245-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28116.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marian Harkin (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the regulation after having worked on the file over a number of months.</p>
<p class="contents">Firstly, I believe it will bring more certainty to the EU regulatory environment for veterinary medicines compared to the current situation where legislation is fragmented across different areas. This regulation will also help increase the availability of veterinary medicinal products by removing red tape and allowing for the harmonisation of the summaries of product characteristics. This will benefit originator and generic manufacturers which will hopefully lead to greater availability and more competitive prices. I supported reducing the Commission’s proposal for the protection of technical documentation for the first marketing authorisation by originator drug companies from 18 years to 14 years.</p>
<p class="contents">In addition to that, I was very happy to note that the regulation clearly aims at combating anti-microbial resistance which is of particular concern to health professionals. I was also very happy that salmon will be contained within the scope of the regulation. Finally, I was happy to support the amendments which called for the continuity of the use of homeopathy in animals. This contributes to the reduction of the use of antibiotics and allows for consumers to continue using these practices.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-246-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124715.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">György Hölvényi (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet idáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A Környezetvédelmi, Közegészségügyi és Élelmiszer-biztonsági Bizottság által jóváhagyott szöveg kiemelten kezeli az állatgyógyászati készítmények elérhetőségének problémáját, amelyre az innováció megerősítése nyújthat megoldást. Az állatgyógyászati készítmények piaca ugyanis kicsi és rendkívül széttagolt, az ágazati szereplők így csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés kiemelten kezeli a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott háromoldalú egyeztetésekhez. Jó lépés a megfelelő irányba.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-246-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124957.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mike Hookem (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-246-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96857.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cătălin Sorin Ivan (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I have voted for this report since there must be a regulation that sets more efficient and effective access to veterinary medicines. Moreover, such a regulation will also promote competitiveness within the sector, while reducing the administrative burden.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-247-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124754.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivan Jakovčić (ALDE), </span></span>  <span class="italic">napisan. ‒ </span>Glasovao sam za nacrt zakonodavne rezolucije Europskog parlamenta o prijedlogu uredbe Parlamenta i Vijeća o veterinarsko-medicinskim proizvodima zbog toga što smatram da je potrebno osigurati dostupnost sigurnim, učinkovitim i povoljnim proizvodima diljem Unije potičući njihovu odgovornu uporabu. Od posebne je važnosti borba protiv rastuće antimikrobne rezistencije, te je nastavno tome velika pozornost usmjerena na poboljšanje regulatornog okvira vezanog uz razumnu upotrebu antimikrobnih sredstva za liječenje životinja. Također, nužno je smanjiti administrativno opterećenje za sve uključene aktere, što predstavlja stav ALDE grupe, te stoga podržavam ovo izvješće. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-247-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124939.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Diane James (EFDD),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-247-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124728.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Joulaud (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur du rapport de ma collègue Françoise Grossetête sur la proposition de règlement du Parlement européen et du Conseil relatif aux médicaments vétérinaires. L'objectif de ce rapport est de lutter contre la résistance aux antibiotiques et donc de limiter l'utilisation d'antimicrobiens. Ainsi le Parlement européen demande l'interdiction des traitements antibiotiques collectifs et préventifs et souhaite que de nouveaux produits de remplacement soient élaborés. J'approuve donc ce rapport qui veut combattre l'antibiorésistance et la présence d'antibiotiques dans les assiettes des Européens tout en encourageant l'innovation dans la recherche.</p>
<p class="contents">Ce rapport a été adopté à une large majorité, ce dont je me félicite.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-247-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125024.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Barbara Kappel (ENF), </span></span>  <span class="italic">schriftlich. ‒ </span>Es war meines Erachtens nach die richtige Entscheidung, die Abstimmung zu verschieben und direkt Verhandlungen im Trilog aufzunehmen. Zwar kann die Berichterstatterin schlüssig darstellen, dass die vorgeschlagene Verordnung der Kommission mit den Änderungen seitens der Berichterstatterin zur Erreichung der Ziele beitragen könnte, jedoch hätte die Vielzahl an Änderungsanträgen ein klares Abstimmverhalten beeinträchtigt und letztlich eine unausgegorene Verordnung zur Folge gehabt.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124962.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Afzal Khan (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the proposal as it provides better access to veterinary medicines, takes measures to fight antimicrobial resistance, reduces the administrative burden, and promotes innovation and competitiveness within the sector.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96829.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ádám Kósa (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet ezidáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A Környezetvédelmi Bizottság által jóváhagyott szöveg kiemelten kezeli az állatgyógyászati készítmények elérhetőségének problémáját, amelyre az innováció megerősítése nyújthat megoldást. Az állatgyógyászati készítmények piaca ugyanis kicsi és rendkívül széttagolt, az ágazati szereplők így csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés kiemelten kezeli a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott trilógusokhoz. Jó lépés a megfelelő irányba. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0140"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96882.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Elisabeth Köstinger (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich habe für den Bericht gestimmt, weil er einen wichtigen Schritt im Kampf gegen Antibiotikaresistenzen bedeutet: Tiergesundheit braucht eine gesicherte Versorgung mit hochwertigen Arzneimitteln und eine richtige Anwendung in der Praxis.</p>
<p class="contents">Nur so kann auch die öffentliche Gesundheit geschützt werden und unverantwortlicher Umgang mit Antibiotika bekämpft werden.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0148"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96816.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Giovanni La Via (PPE),</span></span>   <span class="italic">per iscritto</span><span class="bold">. –</span> La plenaria ha licenziato oggi un testo importante e vorrei ringraziare l'on. Grossetête per l'ottimo lavoro svolto in questi mesi. </p>
<p class="contents">Il testo ha tra i suoi obiettivi principali la protezione della salute animale e, di conseguenza, della salute umana. Esso mira a lottare contro la resistenza agli antibiotici, aumentando al contempo la competitività dei nostri allevamenti e delle industrie facenti capo alla medicina veterinaria. Uno spazio importante viene destinato al ruolo del veterinario, di cui vengono sottolineate l'importanza del lavoro e la professionalità, senza una riduzione dell'arsenale terapeutico a sua disposizione. È invece prevista una riduzione dei medicinali fuori autorizzazione, che continuano ad essere immessi sul mercato. </p>
<p class="contents">Si gettano, inoltre, le basi per un nuovo sistema di farmacovigilanza che sarà più flessibile, più efficace e meno burocratico.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0156"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/101580.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Constance Le Grip (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai apporté mon soutien au rapport de ma collègue Françoise GROSSETÊTE sur les médicaments vétérinaires visant à modifier entièrement la législation existante en réservant certaines substances à la médecine humaine, en encadrant leur prescription et en interdisant la vente en ligne d'antibiotiques et leur usage routinier. </p>
<p class="contents">Ces mesures devraient bénéficier aux consommateurs, qui retrouveront moins d'antibiotiques dans leur assiette, et aux éleveurs, qui bénéficient ainsi de règles claires et applicables sans que l'arsenal thérapeutique des vétérinaires soit réduit. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0171"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28210.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marine Le Pen (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté contre le rapport sur les médicaments vétérinaires. Les grandes préoccupations qui ont sous-tendu les propositions sont la lutte contre l'antibiorésistance et l'assurance de la meilleure disponibilité possible des médicaments. Sous cet objectif se cache en fait une libéralisation de la vente des médicaments, notamment par des sites de vente en ligne, soustrayant cette source de revenus aux vétérinaires, plus à même de délivrer les produits. </p>
<p class="contents">Même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelle sanitaire. Il autorise en outre la prescription de certains médicaments par des non-vétérinaires à cause de l'Angleterre, ce qui est inacceptable pour des raisons de santé publique. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125684.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Philippe Loiseau (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'objectif de ce rapport est de réglementer la mise sur le marché et la circulation des médicaments vétérinaires. Les mesures soumises au vote répondent à la volonté générale de lutter contre l'antibiorésistance et d'assurer une disponibilité optimale des médicaments. Or, l'adoption d'une telle réglementation va faciliter la libéralisation des médicaments et profiter aux sites de vente en ligne ou encore, notamment, autoriser des non-vétérinaires à prescrire certains médicaments, ce qui bafoue les intérêts de nos vétérinaires. </p>
<p class="contents">La Commission, non seulement, libéralise à outrance un sujet de santé publique, mais elle met aussi en danger une profession essentielle. J'ai donc voté CONTRE ce texte.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125042.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Javi López (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establece la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96812.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Juan Fernando López Aguilar (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la reforma mejorará la eficiencia y la disponibilidad de medicamentos en Europa. También porque contribuye a la protección de la salud humana y del medio ambiente y aborda el uso responsable de antibióticos para tratar los animales enfermos con el fin de evitar posibles consecuencias negativas para la salud humana, tales como la resistencia a los antimicrobianos.</p>
<p class="contents">Según establece la Agencia Europea de Medicamentos (EMA), se debe limitar su uso para fines profilácticos a supuestos muy excepcionales, así como establecer una lista de antibióticos reservados para uso humano. Los medicamentos de uso humano deberían utilizarse únicamente como último recurso en el tratamiento de los animales. Por último, el informe incluye una referencia cruzada con la nueva normativa sobre medicamentos veterinarios y el papel de la EMA en la autorización y supervisión de productos veterinarios mediante un procedimiento centralizado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0281"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125047.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Paloma López Bermejo (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor del presente informe porque considero que, pese a que discrepo en importantes puntos, supone una mejora de la legislación en este ámbito en un momento de vigente necesidad. El informe incluye referencias muy positivas al papel exclusivo que deben desempeñar los veterinarios en la prescripción de este tipo de medicamentos; igualmente el informe se refiere positivamente a la necesidad de evaluar el impacto ambiental de los medicamentos en el medio ambiente, la inclusión de las pequeñas y medianas empresas, la prevención de sufrimientos innecesarios en los animales, etc. Este Reglamento resulta muy necesario frente a las crisis que está sufriendo el sector ganadero, con elementos como la extensión de la tuberculosis entre otras enfermedades que necesitan la disponibilidad de este tipo de medicamentos veterinarios. Es por todo esto por lo que he decidido votar a favor del presente informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0312"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28399.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Antonio López-Istúriz White (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>El informe que estamos tratando surge a raíz de un nuevo proyecto de Reglamento de la Comisión Europea para refundir toda la legislación existente hasta el momento relativa a los medicamentos veterinarios.</p>
<p class="contents">A mi parecer, este informe debe ser apoyado, por un lado, porque tiene como objetivo unificar la autorización, la fabricación, la comercialización y la distribución de medicamentos veterinarios y, por otro, porque garantiza el acceso a los mismos y reduce las cargas administrativas, estimulando así la innovación y la competitividad del sector y garantizando el buen funcionamiento del mercado interior.</p>
<p class="contents">Debido a las características específicas de este sector, la prioridad del informe es una diferenciación clara con el mercado de medicamentos humanos.</p>
<p class="contents">Muestro mi apoyo igualmente a algunas de las ambiciones del mismo, como son la incorporación de una prohibición a la venta en línea de estos antibióticos y la ampliación de las medidas destinadas a fomentar la innovación de este sector, aumentando los periodos de protección de los datos, de estudios y de nuevos ensayos. </p>
<p class="contents">Por todo esto voto a favor de esta propuesta.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0343"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119436.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivana Maletić (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Direktiva 2001/82/EZ i Regulacija (EZ) br. 726/2004 definiraju procedure za autorizaciju i nadzor medicinskih proizvoda za ljude i životinje. Cilj ovog Izvješća je objediniti instrumente za veterinarske proizvode. Definirani su svi uvjeti u kojima se veterinarski proizvodi mogu koristiti, na koji način i kada se koriste antibiotici za životinje. Ovim Izvješćem se uvodi harmonizacija sustava za korištenje veterinarskih proizvoda, stimulira razvoj veterinarske medicine i posebno vodi računa o smanjenju negativnog učinka na okoliš stoga sam ga podržala.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125069.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νότης Μαριάς (</span></span>  <span class="bold">ECR</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Ψηφίζω υπέρ της αναβολής της ψηφοφορίας της έκθεσης σχετικά με την πρόταση κανονισμού του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου για τα κτηνιατρικά φάρμακα συμφωνώντας με τη σχετική πρόταση του εισηγητή.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124751.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Martin (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté contre ce texte. Ce projet de rapport vise à réglementer la mise sur le marché et la circulation des médicaments vétérinaires. Les grandes préoccupations qui ont sous-tendu les propositions sont la lutte contre l'antibiorésistance et l'assurance de la meilleure disponibilité possible des médicaments. Sous cet objectif se cache en fait une libéralisation de la vente des médicaments, notamment par des sites de vente en ligne, soustrayant cette source de revenus aux vétérinaires, plus à même de délivrer les produits. </p>
<p class="contents">Même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelle sanitaire. Il autorise en outre la prescription de certains médicaments par des non-vétérinaires à cause de l'Angleterre, ce qui est inacceptable pour des raisons de santé publique (exemple de la "vache folle").</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-248-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124828.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Fulvio Martusciello (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Sono favorevole alla proposta di regolamento del Parlamento europeo e del Consiglio relativo ai medicinali veterinari.</p>
<p class="contents">L'esistenza di tali medicinali, efficaci e accessibili, ad un prezzo ragionevole, risulta fondamentale per ampliare gli ambiti della ricerca e dello sviluppo, aumentare la produzione di medicinali veterinari e la loro redditività nel mercato interno. </p>
<p class="contents">È quindi necessaria una normativa che sia esplicita e quanto più semplice possibile per migliorare l'accesso ai farmaci, ridurre gli oneri amministrativi, stimolare la competitività e l'innovazione, così da rendere disponibili medicinali nuovi e migliori per la cura e la prevenzione delle malattie animali, evitando contemporaneamente di danneggiare l'ambiente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1403.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">David Martin (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I welcome the Commission’s draft regulation, I believe that it is a move in the right direction and fully agree with the Commission’s objectives and its view that the veterinary medicines market should be separated from the human medicines market, which works very differently. The Commission is right to stress the importance of product availability and simpler administrative procedures without sacrificing the principles of public health and the protection of the environment. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96813.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Barbara Matera (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>La resistenza antibiotica pone una vera minaccia per la nostra salute, specialmente per quanto riguarda gli animali che si nutrono di carne. Per questa ragione sono contenta che questa relazione richiami a una raccolta di dati dettagliati al livello degli Stati membri, i quali devono essere in prima linea per la soluzione di questi problemi. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0515"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96820.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marisa Matias (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Votei a favor, por considerar que, ao longo dos anos, se tornou evidente que, relativamente aos medicamentos, as questões e as necessidades do setor veterinário e do setor humano eram distintas, uma vez que a existência de múltiplas espécies implica um maior investimento, por exemplo, na extensão das autorizações dos medicamentos existentes de umas espécies para as outras.</p>
<p class="contents">Também a definição de preços deve seguir uma lógica própria, sob pena de se criarem diversas dificuldades acrescidas na disponibilidade de medicamentos para setores mais pequenos de mercado, como as abelhas. </p>
<p class="contents">É, pois, fundamental um enquadramento legal distinto para os medicamentos de uso veterinário.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0523"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96936.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gabriel Mato (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>El nuevo Reglamento sobre los medicamentos veterinarios, que cuenta con mi voto a favor, regulará mejor la autorización, la fabricación, la comercialización, la distribución y la utilización de estos productos, así como la vigilancia.</p>
<p class="contents">Desde este Parlamento hemos planteado algunas mejoras al texto propuesto por la Comisión, y estoy seguro de que el texto final va a permitir mejorar el acceso a los medicamentos y su disponibilidad, especialmente por lo que se refiere a las especies llamadas menores, reducir las cargas administrativas, en particular por lo que se refiere al procedimiento de farmacovigilancia, estimular la innovación y la competitividad del sector, velar por el buen funcionamiento del mercado interior de medicamentos veterinarios y luchar contra la resistencia a los antibióticos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0531"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124691.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Κώστας Μαυρίδης (</span></span>  <span class="bold">S</span><span class="bold">&amp;</span><span class="bold">D</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Η πρόσφατη πρόταση της Επιτροπής για τη θεσμοθέτηση νέου κανονισμού αναφορικά με τα κτηνιατρικά φάρμακα αναθεωρεί πλήρως την ισχύουσα νομοθεσία (oδηγίες 2001/82/ΕΚ και ΕΚ 726/2004). Ο νέος κανονισμός θα ρυθμίζει εξ ολοκλήρου τη διαδικασία παρασκευής, αδειοδότησης, προώθησης, διανομής και χρήσης των κτηνιατρικών φαρμάκων από τους ενδιαφερομένους.</p>
<p class="contents">Η ανάγκη ενός σύγχρονου ρυθμιστικού πεδίου το οποίο να αντικατοπτρίζει τις ιδιαίτερες ανάγκες του κτηνιατρικού τομέα σε ευρωπαϊκό και εθνικό επίπεδο με ώθησε στο να υπερψηφίσω τη συγκεκριμένη πρωτοβουλία.</p>
<p class="contents">Από τους σκοπούς της πρότασης από την Επιτροπή, κρίνω επιθυμητούς και αναγκαίους, τη βελτίωση της πρόσβασης στα κτηνιατρικά φάρμακα ακόμα και για τις μικρότερες αγορές, θέμα που πρέπει να ληφθεί ιδιαίτερα υπόψη και θα βοηθήσει στη γενικότερη αύξηση της διαθεσιμότητας των προϊόντων αυτών μέσω και της μείωσης των διοικητικών βαρών για τη διάθεσή τους. Παράλληλα, στοχεύει στην προώθηση και ενίσχυση της ανταγωνιστικότητας και καινοτομίας της αγοράς των κτηνιατρικών φαρμάκων παραχωρώντας κίνητρα για νέες ιδέες και βελτίωση της ποιότητας των υφιστάμενων φαρμάκων.</p>
<p class="contents">Ιδιαίτερη σημασία πρέπει να δοθεί στο θέμα των αντιβιοτικών και συγκεκριμένα στον καθορισμό των όρων και προϋποθέσεων για την παραχώρησή τους και στην απαγόρευση διανομής τους μέσω του διαδικτύου. Η προστασία του περιβάλλοντος παραμένει εντέλει, καθοδηγητικό εργαλείο στην όλη προσπάθεια.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0538"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124768.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Valentinas Mazuronis (ALDE), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau dėl EK pasiūlymo reglamentui dėl veterinarinių vaistų. Šiuo teisės aktu siekiama reglamentuoti veterinarinių vaistų leidimų suteikimą, gamybą, rinkodarą, veterinarinių vaistų platinimą ir naudojimą, supaprastinti žmonėms skirtų be rinkodaros leidimo parduodamų vaistų naudojimą gyvūnams gydyti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0542"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28115.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mairead McGuinness (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of this report that aims to ban preventative use of antibiotics and restrictions of their use in the treatment of animals, while also supporting innovation in this sector.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0546"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124765.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Joëlle Mélin (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Ce projet de rapport vise à réglementer la mise sur le marché des médicaments vétérinaires. Derrière la louable volonté d'une meilleure disponibilité des médicaments et une lutte contre la résistance aux antibiotiques se tapit le libéralisme. Il faut dire que les groupes pharmaceutiques ont été partie prenante de la libéralisation de la vente des médicaments. </p>
<p class="contents">Je reconnais que ce rapport est plus mâtiné que celui de la Commission, mais la prescription qu'il autorise pour les personnes n'étant pas vétérinaires est déraisonnable au regard de la santé publique. Plus fondamentalement, il va contre les intérêts des vétérinaires qui demeurent par leur travail des garants sanitaires.</p>
<p class="contents">Aussi ai-je voté contre ce texte.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0550"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96978.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nuno Melo (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>É extremamente importante uma nova legislação, com vista a alargar o âmbito para a investigação, o desenvolvimento e a monitorização dos medicamentos veterinários. </p>
<p class="contents">Os agricultores precisam de ter à sua disposição medicamentos eficazes, acessíveis e a preços razoáveis.</p>
<p class="contents">Importa que se conheça mais sobre a resistência antimicrobiana, que representa uma ameaça séria para os seres humanos e para os animais.</p>
<p class="contents">Daí que tenha votado a favor da proposta de regulamento do Parlamento Europeu e do Conselho relativo aos medicamentos veterinários.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0554"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118859.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Roberta Metsola (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I chose to support this resolution as it builds upon the work done by the Commission to separate the veterinary medicinal market from the human medicinal market as well reducing the red tape, maintaining the principles of public health and protecting the environment. I also supported the proposed measures to curb antimicrobial resistance.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0558"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96670.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Louis Michel (ALDE),</span></span>   <span class="italic">par écrit</span><span class="bold">. –</span> Présente de manière croissante partout dans le monde, l'antibiorésistance fait peser une grave menace sur la santé publique. Dans les années à venir, la résistance des bactéries aux antibiotiques posera donc un véritable défi sanitaire. Étroitement lié à l'administration d'antibiotiques aux animaux d'élevage, le problème de l'antibiorésistance doit être attaqué à la source.</p>
<p class="contents">Le législateur européen se doit donc d'adopter au plus vite des dispositions relatives aux médicaments vétérinaires. À ce titre, je me réjouis de l'adoption par le Parlement de sa position sur la proposition législative concernant les médicaments vétérinaires. L'usage d'antibiotiques dans les élevages doit faire l'objet d'un encadrement strict afin de le limiter à ce qui est strictement nécessaire et d'éviter tout recours abusif, indifférencié ou systématique des antibiotiques sur les animaux destinés à la chaîne alimentaire. </p>
<p class="contents">Outre l'encadrement de l'utilisation des antibiotiques, l'accent doit être mis sur la recherche d'alternatives à ces médicaments. L'innovation doit être encouragée afin de garantir un recours aussi restreint que possible aux antibiotiques et de pérenniser ainsi leurs effets. Il s'agit là d'une problématique urgente à laquelle nous devons consentir tous nos efforts. Il en va de notre santé à tous.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0562"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28178.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miroslav Mikolášik (PPE),</span></span>   <span class="italic">písomne</span><span class="bold"> –</span> Nové nariadenie by predstavovalo samostatnú právnu úpravu o veterinárnych liekoch, separátnu od úpravy regulujúcej ľudské liečivá. Je reakciou na zmeny prebiehajúce v oblasti veterinárnej medicíny a farmácie, ktoré by prirodzene mala zohľadňovať aktuálna legislatíva. Nariadenie si kladie za cieľ úpravu procesu povoľovania veterinárnych liekov, ich výroby, distribúcie, predaja, farmakovigilancie a používania počas doby ich životnosti. Považujem za dôležité, že nariadenie bude adresovať otázky, ako zlepšiť prístup k veterinárnym liečivám a zabezpečiť ich širšiu dostupnosť, ako reagovať na problémy súvisiace s trendom zvyšujúcej sa odolnosti zvierat voči antibiotikám, povzbudiť inovácie či chrániť životné prostredie. Nové nariadenie by malo zohľadniť návrhy predložené v predkladanej správe, ktoré sa týkajú úplného zákazu predpisovania antibakteriálnych látok na preventívne účely, určenia doby ochrany údajov 14 rokov s možnosťou predĺženia, problematiky uznávania lekárskych predpisov v jednotlivých členských štátoch, požiadaviek na označovanie veterinárnych liekov, zlepšenia a zjednodušenia procesu autorizácie a predaja veterinárnych liečiv, a pod. Hlasujem preto za predložený návrh.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118858.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marlene Mizzi (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I have voted in favour of the report on the veterinary medicinal products in order to have a regulation that provides better access to veterinary medicines, takes measures to fight antimicrobial resistance, reduces the administrative burden, and promotes innovation and competitiveness within the sector.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0656"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124761.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bernard Monot (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Le projet de rapport a pour objectif de réglementer la mise sur le marché et la circulation des médicaments vétérinaires, avec comme préoccupations principales la lutte contre l'antibiorésistance et la meilleure disponibilité possible de ces médicaments.</p>
<p class="contents">Ce rapport porte atteinte aux intérêts de notre médecine vétérinaire, notamment car il propose d'autoriser la prescription de médicaments par des non-vétérinaires, ce qui présente en plus un véritable risque sanitaire.</p>
<p class="contents">Nous votons contre ce rapport.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0671"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124734.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cláudia Monteiro de Aguiar (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Os medicamentos veterinários são, até à presente data, regulados pela Diretiva 2001/82/CE e pelo Regulamento (CE) n.º 726/2004.</p>
<p class="contents">Defendo que existe a necessidade de nova legislação, com o objetivo de alargar o âmbito para a investigação, o desenvolvimento e a monitorização dos medicamentos veterinários e de aumentar a produção e a rendibilidade no mercado interno.</p>
<p class="contents">Foram detetadas algumas falhas no atual enquadramento legal, designadamente a falta de disponibilidade de medicamentos veterinários, os encargos administrativos impostos pela regulamentação, o funcionamento do mercado interno e a resistência aos antibióticos.</p>
<p class="contents">Importa salientar a complexidade da produção de medicamentos veterinários, em alguns casos mais intrincada que a produção dos medicamentos para uso humano, devido à fragmentação do mercado. Defendo que as leis e os regulamentos relativos ao desenvolvimento de medicamentos veterinários sejam claros, explícitos e simples.</p>
<p class="contents">Considero fundamental que se amplifiquem as medidas de promoção da inovação e que a saúde pública e a proteção do ambiente estejam sempre salvaguardadas.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124769.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sophie Montel (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelle sanitaire. Il autorise en outre la prescription de certains médicaments par des non-vétérinaires à cause de l'Angleterre, ce qui est inacceptable pour des raisons de santé publique (exemple de la vache folle). S'il n'avait pas été reporté, j'aurais voté contre.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0718"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/72779.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nadine Morano (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Je soutiens ce rapport. J'ai notamment voté en faveur de toutes les dispositions qui permettent de limiter l'usage abusif des antibiotiques dans les élevages, notamment en interdisant leur vente en ligne et leur usage routinier. </p>
<p class="contents">Le fait de retrouver systématiquement certaines molécules dans la viande consommée par les humains peut, à terme, créer une résistance qui ne permettra plus de soigner certaines maladies. Il était donc urgent de réformer la législation en matière de médicaments vétérinaires. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0734"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124729.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Renaud Muselier (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Je n'ai pu, pour raison médicale, assister à la séance plénière du 7 au 10 mars 2016. Néanmoins, je tiens à faire part de mon soutien au rapport sur les médicaments vétérinaires et humains. </p>
<p class="contents">Ce rapport, notamment, vise à l'amélioration de l'accès aux médicaments, à l'innovation et au respect de l'environnement. Il contient également d'importantes clarifications concernant les attributions des médecins vétérinaires dans la prescription et la vente d'antibiotiques. </p>
<p class="contents">Je sais l'importance du travail des médecins et vétérinaires. Je suis donc largement en faveur du présent rapport tel qu'établi par Mme Grossetête.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124926.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">József Nagy (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Üdvözlöm a Bizottság által kidolgozott, állatgyógyászati készítményekről szóló új rendelettervezetet, melynek célja az állatgyógyászati készítményekkel kapcsolatos eljárások szabályozása. A jelentés egy új szabályozási keretet kíván bevezetni, aminek célja az ágazati innováció és verseny fellendítése, a gyógyszerek elérhetőségének javítása és az adminisztratív terhek lényeges csökkentése. Különösen pozitívnak látom azokat a javaslatokat, amelyek szorgalmazzák az állatgyógyászati készítmények piacának megkülönböztetését az emberi felhasználásra szánt gyógyszerek piacától.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0781"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/88882.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Victor Negrescu (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>The Commission published its new draft regulation on veterinary medicinal products in September 2014. I have voted for this report that will improve the existing rules on medicinal products for veterinary use set out in Directive 2001/82/EC and Regulation EC 726/2004.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124701.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Luděk Niedermayer (PPE), </span></span>  <span class="italic">písemně. ‒ </span>Podpořil jsem zprávu o veterinárních léčivých přípravcích, která zkvalitňuje stávající právní úpravu a vytváří podmínky pro zlepšení veterinární péče. Za její důležitý prvek považuji boj proti antibakteriální rezistenci, která trápí stále více zemědělců a chovatelů. Považuji za správné, že podmínkou vystavení předpisu na veterinární přípravek je stanovení veterinární diagnózy na základě klinického vyšetření zvířete a nestačí jeho soustavné zdravotnické sledování.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0843"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96981.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franz Obermayr (ENF), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich habe mich für diesen Bericht ausgesprochen, da meiner Meinung nach eine Überarbeitung des EU-Gesetzes zu Tierarzneimitteln notwendig ist. Des Weiteren spreche ich mich auch für die Förderung der Erforschung neuer Medikamente in diesen Bereich aus. Der Berichterstatter hat die Lage schlüssig dargestellt, so dass die genannten Ziele wie gewünscht erreicht werden können.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/129073.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Urmas Paet (ALDE), </span></span>  <span class="italic">kirjalikult. ‒ </span>Toetasin. Veterinaarravimite väljatöötamise jaoks on oluline vastavate õigusnormide ja eeskirjade olemasolu ning nende võimalikult suur lihtsus. Samas peaks rohkem tähelepanu pöörama võitlusele antimikroobikumiresistentsuse vastu. See on valdkond, mis vajab suuremat tähelepanu, kuna puudutab otseselt ka inimesi.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0890"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96694.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Rolandas Paksas (EFDD), </span></span>  <span class="italic">raštu. ‒ </span>ES turi būti taikoma bendra teisės sistema, kuri tinkamai apsaugotų visuomenės sveikatą, gyvūnų sveikatą ir aplinką bei užtikrintų maisto saugą. Naujasis teisinis reguliavimas turi būti proporcingas, pritaikytas prie veterinarijos sektoriaus specifikos. Pažymėtina, kad veterinarijos ir žmonių medicinos sektorių poreikiai, susiję su vaistais, gerokai skiriasi. Todėl turi būti taikomas ir skirtingas reguliavimo mechanizmas. </p>
<p class="contents">Atsižvelgiant į atsparumo antimikrobinėms medžiagoms plitimą, būtina kuo skubiau spręsti su atsparumo antimikrobinėms medžiagoms visuomenės sveikatai keliama rizika susijusį klausimą. Turi būti kuriamos paskatos naujų gyvūnų ligų gydymui ir profilaktikai skirtų vaistų kūrimui. </p>
<p class="contents">ES turi būti sukurta efektyviai funkcionuojanti bendroji veterinarinių vaistų rinka, kuri didintų veterinarinių vaistų prieinamumą, skatintų konkurencingumą ir inovacijas bei mažintų administracinę naštą. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0906"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124945.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Margot Parker (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines should be used responsibly, under veterinary care and according to licensing conditions.</p>
<p class="contents">With regard to economic incentives provided by pharmaceutical companies, whilst recognising the issues surrounding commercial practice and the specific use of incentives in the human and veterinary healthcare sectors, UKIP is concerned about a negative impact on the provision of cost benefit analyses and other health economic data and studies by neutral and independent academic research institutions.</p>
<p class="contents">This is an area where the UK and USA institutions are world leaders and thus unnecessary EU interference has the potential to adversely affect their investigative work and its applications.</p>
<p class="contents">UKIP believes that the EU should have no jurisdiction in what is a global arena for drug development and cannot enforce the removal of products from the market in this manner – this would penalise leading drug development companies including world-leading UK corporations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0921"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23693.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alojz Peterle (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Predlog poročevalke sem podprl, saj predstavlja pomemben korak k večjemu nadzoru na področju veterinarskih medicinskih produktov. Tako bomo lažje nadzirali področje odobritve, izdelave, trženja in ugotavljanja življenjske dobe zdravil.</p>
<p class="contents">Stremimo k zagotovljanju pogojev za boljši dostop do zdravil, povečanje števila inovacij, predvsem na področju odpravljanja odpornosti bakterij na antibiotike, ter k varovanju okolja.</p>
<p class="contents">Hkrati ta predlog podpiram tudi zaradi potrebe po opredelitvi okoliščin, kdaj lahko veterinar predpiše in proda antibiotično zdravilo, s čimer želimo zmanjšati prekomerno uporabo antibiotikov v živinoreji, ki povzroča vedno večjo odpornost bakterij na zdravila.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marijana Petir (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Podržala sam odgodu glasovanja i početak pregovora o ovom izvješću s Vijećem i Komisijom. Odluku da primjena profilaktičkih antimikrobnih veterinarskih lijekova bude dozvoljena za upotrebu samo kad se radi o pojedinačnim životinjama i kada se veterinari na to odluče iz opravdanih razloga i u iznimnim slučajevima ocjenjujem dobrom. Upotreba metafilaktičkih antimikrobnih veterinarskih lijekova biti će ograničena na korištenje kod klinički bolesnih životinja i pojedinačnim slučajevima, kada postoji opasnost od širenja bolesti.</p>
<p class="contents">Zalažem se za postrožavanje kriterija kada govorimo o veterinarskim lijekovima jer se radi o zdravlju svih nas koji konzumiramo meso i mesne prerađevine. </p>
<p class="contents">Osobitu pozornost pridajem internetskoj prodaji, gdje pravila postaju stroža, odnosno antimikrobna sredstva, biološki i imunološki veterinarsko-medicinski proizvodi ne smiju biti ponuđeni na prodaju putem interneta.</p>
<p class="contents">Također podsjećam na važnost zaštite zdravlja životinja i eventualne posljedice kojima bi iste bile izložene neodgovornom upotrebom lijekova.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0938"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112744.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tonino Picula (S&amp;D), </span></span>  <span class="italic">napisan. ‒ </span>Pravni okvir za veterinarsko-medicinske proizvode potrebno je prilagoditi znanstvenom napretku, trenutačnim uvjetima na tržištu i gospodarskoj stvarnosti poštujući životinje, prirodu i njihovu interakciju s čovjekom. </p>
<p class="contents">Životinje mogu oboljeti od čitavog niza bolesti koje se moraju spriječiti ili liječiti veterinarsko-medicinskim proizvodima kako bi se osiguralo njihovo zdravlje, a naša je uloga zajamčiti da farmaceutske tvari ili veterinarsko-medicinski proizvodi proizvedeni ili stavljeni na tržište nemaju štetno djelovanje na zdravlje ljudi ili životinja ni bilo kakav neprihvatljiv utjecaj na okoliš. </p>
<p class="contents">Iz tog razloga podupirem ovu Uredbu o veterinarsko-medicinskim proizvodima kojom se pruža bolji pristup veterinarskim lijekovima, poduzimaju mjere u borbi protiv antimikrobne rezistencije, smanjuje teret administrativnih postupaka i prepreka te potiču istraživanja, inovacije i konkurentnost u sektoru.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0940"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/136236.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">João Pimenta Lopes (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Identificamos elementos positivos no relatório. A garantia da produção de medicamentos veterinários seguros, eficazes e acessíveis é relevante para os nossos produtores. Igualmente importante e correta é a introdução da questão dos medicamentos genéricos, das resistências antimicrobianas ou dos pequenos mercados.</p>
<p class="contents">É grande e evidente a pressão exercida pelas grandes multinacionais farmacêuticas sobre as instituições da UE, procurando alargar ao máximo os seus privilégios e proveitos.</p>
<p class="contents">Nesse sentido, fica aquém na salvaguarda dos interesses dos países mais pequenos, de forma a evitar que as multinacionais disponibilizem os seus produtos apenas nos mercados mais rentáveis.</p>
<p class="contents">A proposta da Comissão Europeia defende o interesse das multinacionais farmacêuticas, propondo o prolongamento dos períodos de proteção da documentação no que diz respeito aos antibióticos (18 anos em vez de 14) e a inclusão de espécies principais no âmbito da autorização de introdução no mercado (dois anos suplementares em vez de um).</p>
<p class="contents">Além disso, prevê a possibilidade de instaurar um período de proteção de 5 anos (não cumulativos) para certos estudos ou ensaios novos pós-autorização.</p>
<p class="contents">Apresentámos propostas de alteração para baixar estes períodos de proteção de documentos, de modo a que seja possível às empresas de genéricos e às pequenas e médias empresas aceder e entrar no mercado.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0942"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112755.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andrej Plenković (PPE),</span></span>   <span class="italic">napisan</span><span class="bold">. –</span> Podržavam izvješće kolegice Grossetete. S obzirom da se potrebe i značajke veterinarskog sektora razlikuju od onog humanog te oba tržišta lijekova funkcioniraju drugačije, smatram nužnim uspostavljenje novog regulatornog okvira za veterinarske lijekove. Uostalom, sama proizvodnja to nalaže. </p>
<p class="contents">Proizvodnja veterinarsko-medicinskih proizvoda smatra se zahtjevnijom i financijski izdašnijom zbog tržišne necjelovitosti uzrokovane količnom različitih životinjskih vrsta. Nužno je privući veći broj investitora iako je cijena samih lijekova niža od onih za ljudsku potrošnju. Nemoguće je primijeniti model tržišta lijekova za ljudsku potrošnju na lijekove za životinje. Usto, ovom uredbom bi se ostvario cilj veće dostupnosti veterinarsko-medicinskih proizvoda stanovništvu koje se bavi primjerice uzgojem stoke. Sukladno životinjskoj vrsti, mogu se pojaviti različite bolesti te je nužno da se ovom uredbom osigura visoki standard zdravlja životinja. On se postiže unaprijeđivanjem veterinarsko- medicinskih proizvoda u vidu kakvoće, neškodljivosti i djelotvornosti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0944"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/108080.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franck Proust (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai apporté mon soutien à ce rapport qui vise à mettre à jour la législation européenne en matière de médicaments vétérinaires. Parce qu'il présentait des dangers, le traitement antibiotique collectif et préventif des animaux devait être interdit. Très simplement, un des objectifs est d'éviter que trop d'antibiotiques se trouvent dans l'assiette des consommateurs. </p>
<p class="contents">Néanmoins, les moyens thérapeutiques des vétérinaires ne doivent pas être mis en cause et il est ainsi nécessaire d'encourager la recherche de nouveaux médicaments. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0952"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/106202.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Julia Reid (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines including antibiotics should be used responsibly, under veterinary care and according to licensing conditions. We believe that the British Parliament should be able to legislate on this issue without being overruled by the unelected EU Commission.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0960"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124733.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sofia Ribeiro (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Este relatório aborda a proposta de regulamento da Comissão relativa aos medicamentos veterinários, a qual incorpora uma reformulação total da legislação e tenciona regulamentar a autorização, o fabrico, a introdução no mercado, a distribuição e a utilização dos medicamentos veterinários ao longo de todo o seu ciclo de vida, bem como o processo de farmacovigilância aplicável.</p>
<p class="contents">Votei a favor do presente relatório, por concordar com a necessária diferenciação entre o mercado dos medicamentos veterinários e o mercado dos medicamentos humanos, os quais só devem ser aplicados em último recurso e na ausência de melhor alternativa.</p>
<p class="contents">Em concordância com o exposto neste relatório, apoio a necessidade de assegurar o bom funcionamento do mercado interno em relação aos medicamentos veterinários, o reforço das medidas de incentivo à inovação, assim como a criação de um sistema baseado na apresentação regular de relatórios de farmacovigilância durante os primeiros anos de vida do produto e, posteriormente, na análise dos riscos e na deteção de sinais.</p>
<p class="contents">Face ao exposto, e também por constar do relatório a necessidade de uma atenção especial à proteção do ambiente, votei a favor do mesmo.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-249-0968"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4253.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Frédérique Ries (ALDE), </span></span>  <span class="italic">par écrit. ‒ </span>Ce midi, les députés européens ont adopté le projet de mise à jour de la législation européenne relative aux médicaments vétérinaires. Un vote important dans un contexte inquiétant d'antibiorésistance.</p>
<p class="contents">À ce sujet, le Centre européen de prévention et de contrôle des maladies (ECDC) a récemment averti que les bactéries chez l'homme et les animaux continuent de montrer une résistance aux antimicrobiens les plus utilisés. La résistance à la ciprofloxacine, un antimicrobien extrêmement important pour le traitement d'infections chez l'homme, est particulièrement problématique.</p>
<p class="contents">Un accord s'est dégagé sur les principaux points, en premier lieu desquels l'interdiction de principe de l'usage prophylactique des antibiotiques. Ce qui revient à autoriser uniquement l'administration préventive de médicaments aux animaux sur une base individuelle et seulement lorsque cela est justifié par un vétérinaire. Ce dernier reste au cœur du dispositif, c'est essentiel, et pourra continuer à prescrire et à délivrer les médicaments. </p>
<p class="contents">D'autres limites ont été justement fixées par le Parlement européen, telles l'interdiction de l'usage vétérinaire des antibiotiques critiques pour la médecine humaine ou encore la volonté de mettre fin à la vente sur l'internet d'antibiotiques et de vaccins soumis à prescription. Un accord est désormais à portée de mains avec le Conseil en première lecture. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-250-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125099.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Liliana Rodrigues (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>Votou-se favoravelmente a proposta da Comissão relativa aos medicamentos veterinários. O seu objetivo é regulamentar a autorização, o fabrico, a introdução no mercado, a distribuição e a utilização dos medicamentos veterinários ao longo de todo o seu ciclo de vida, assim como o processo de farmacovigilância aplicável. A proposta da Comissão tem como principais objetivos: melhorar o acesso aos medicamentos e a sua disponibilidade; reduzir os encargos administrativos, nomeadamente no que diz respeito ao processo de farmacovigilância; estimular a inovação e a competitividade do sector; assegurar o bom funcionamento do mercado interno em relação aos medicamentos veterinários e ainda lutar contra a resistência aos antibióticos. A proposta pretende ainda diferenciar vincadamente o mercado dos medicamentos veterinários do mercado dos medicamentos humanos. Discordei apenas do prolongamento dos períodos de proteção da documentação técnica dos medicamentos veterinários, que considero um entrave desnecessário ao acesso ao mercado dos medicamentos genéricos, permitindo estes aumentar a disponibilidade de medicamentos, o acesso em termos financeiros (controlo de preços) aos mesmos e fomentar a própria competitividade. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125043.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Inmaculada Rodríguez-Piñero Fernández (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor del informe sobre la propuesta de Reglamento del Parlamento Europeo y del Consejo sobre los medicamentos veterinarios</p>
<p class="contents">Los medicamentos veterinarios se encuentran regulados en la Directiva 2001/82/CE y en el Reglamento (CE) n.º 726/2004. En el año 2004, la Comisión propuso unir ambos actos, con objetivos como la mejora del acceso a los medicamentos veterinarios, la reducción de la carga burocrática, el análisis de la resistencia a los antibióticos y la promoción de la innovación de la competitividad. </p>
<p class="contents">La cuestión relativa a los medicamentos veterinarios, así como la necesidad de establecer un enfoque global en relación con su uso, hace que sea obligatoria la revisión de la legislación farmacéutica veterinaria. Por ello, el Grupo socialista exige la inclusión de unos objetivos más ambiciosos, como la prohibición del uso de profilácticos en los antibióticos o la clarificación de las condiciones por las cuales los veterinarios prescriben y venden antibióticos, así como la venta en línea de los mismos. Se debe endurecer el marco de los medicamentos humanos para su uso con animales y establecer una serie de medidas preventivas antes de recurrir a tratamientos antimicrobianos de grupos enteros de animales que se encuentran destinados a la producción de alimentos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125107.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Claude Rolin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Le Parlement européen a adopté, jeudi 10 mars en plénière, les amendements à la proposition initiale de la Commission européenne sur les médicaments vétérinaires. Mais il a été décidé de reporter le vote sur le projet de résolution législative "pour procéder directement aux négociations interinstitutionnelles sur la base du mandat adopté". </p>
<p class="contents">Le texte amendé vise à mieux lutter contre la résistance aux antibiotiques dans les élevages, notamment en interdisant l'usage préventif pur (prophylaxie) et en conditionnant l'usage métaphylactique (traitement de tout un troupeau lorsqu'un seul animal est malade). </p>
<p class="contents">À titre personnel, j'ai également soutenu un amendement qui vise à ajouter, aux motifs pouvant justifier un refus d'autorisation de mise sur le marché, le fait que le médicament contienne des OGM (sachant qu'actuellement, 19 vaccins comportant des OGM sont déjà sur le marché).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125214.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bronis Ropė (Verts/ALE), </span></span>  <span class="italic">raštu. ‒ </span>Pritariu turinio prasme tikrai gerai parengtam pasiūlymui.</p>
<p class="contents">Saugių ir prienamų veterinarinių preparatų klausimas yra svarbus visam ES žemės ūkio sektoriui.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4345.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tokia Saïfi (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai soutenu ce rapport qui a pour objectif de lutter contre la résistance croissante des bactéries aux antibiotiques actuels. Ainsi, l'utilisation d'antimicrobiens existants devrait être limitée et de nouveaux produits devraient être élaborés.</p>
<p class="contents">La lutte contre la résistance aux antibiotiques doit commencer dans les élevages et pour ce faire, nous devons faire en sorte que l'usage uniquement préventif des antibiotiques soit interdit, que les traitements de masse soient réduits à des cas bien particuliers ou encore que la vente en ligne d'antibiotiques, de vaccins ou de produits psychotropes soit interdite.</p>
<p class="contents">Avec ces mesures, la quantité d'antibiotique sera réduite.</p>
<p class="contents">En parallèle, il est important de développer des mesures d'encouragement pour favoriser la recherche de nouveaux antimicrobiens. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0468"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125035.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lola Sánchez Caldentey (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Hemos votado A FAVOR de este informe dado que apunta a un mayor control tanto del ciclo de venta de los antibióticos como del uso de los mismos. Limita la venta en internet de medicinas que deberían venderse con prescripción médica, se limita y controla el uso de forma preventiva y se refiere a otras cuestiones que atañen a criterios de bienestar animal. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/33989.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Daciana Octavia Sârbu (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I welcome this report. The measures contained in it, especially those concerning prophylactic and metaphylactic use of antibiotics and restrictions on internet sales, should help in the struggle against antimicrobial resistance. At the same time, the distribution of essential veterinary medicines throughout the EU should be increased and the administrative burden reduced.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/37312.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Christel Schaldemose (S&amp;D), </span></span>  <span class="italic">skriftlig. ‒ </span>Vi er i Europa-Parlamentet enige om, at brugen af antibiotika til dyr skal begrænses. Vores bud på ny veterinærlovgivning er et godt skridt fremad og viser, hvor alvorligt vi tager problemet. Vi åbner for at reservere bestemte typer af antibiotika til menneskers sundhed, så de ikke må bruges i landbruget og til dyr generelt. Europa skal også om 20 år kunne behandle en simpel lungebetændelse, og det er dette forslag med til at sikre. Set med danske og nordiske øjne burde reglerne være gået endnu længere. Men det foreliggende er trods alt et skridt i den rigtige retning. Derfor støtter jeg aftalen. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124809.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sven Schulze (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich habe dem Berichtsentwurf über Tierarzneimittel zugestimmt, da ich den Vorschlag gut finde, den Tiermedizinprodukten eine gesonderte Verordnung zu widmen und die Humanarzneimittel in der bisherigen Richtlinie 726/2004 zu belassen. Der Bericht befasst sich mit der Verbesserung des Zugangs zu Arzneimitteln sowie damit, den Anreiz zu erhöhen, Neuerungen zu fördern, Antibiotikaresistenz in Angriff zu nehmen und die Umwelt zu schützen.</p>
<p class="contents">Relevant finde ich die generelle Reduzierung der Verwendung von Antibiotika und die Harmonisierung der Anforderungen an eine tierärztliche Verschreibung und Anerkennung von Rezepten.</p>
<p class="contents">Diskussionsbedarf gab es bezüglich der Datenschutzzeit von 14 Jahren für die technische Dokumentation über neue Antibiotika, da es zu Problemen für die Hersteller der Generika kommen könnte. Wir kamen jedoch zu einem Kompromiss.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125049.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lidia Senra Rodríguez (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor del presente informe porque considero que, pese a que discrepo en importantes puntos, supone una mejora de la legislación en este ámbito en un momento de vigente necesidad. El informe refiere positivamente a la necesidad de evaluar el impacto ambiental de los medicamentos en el medio ambiente, la inclusión de las pequeñas y medianas empresas, la prevención de sufrimientos innecesarios en los animales, etc. Este Reglamento resulta muy necesario frente a las crisis que está sufriendo el sector ganadero, con elementos como la extensión de la tuberculosis entre otras enfermedades. Es por todo esto por lo que he decidido votar a favor del presente informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124794.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Remo Sernagiotto (ECR), </span></span>  <span class="italic">per iscritto. ‒ </span>Mi sono espresso a favore della proposta di regolamento votata oggi, che getta le basi per una revisione della legislazione esistente in materia di medicinali veterinari. </p>
<p class="contents">Gli obiettivi previsti dalla relazione riguardano l'accesso a tali farmaci e la loro disponibilità, l'innovazione e lo sviluppo di farmaci di nuova generazione, il buon funzionamento del mercato interno per i farmaci veterinari, la riduzione degli oneri amministrativi e la resistenza agli antibiotici. Su quest'ultimo punto, ritengo importante sottolineare che la proposta disciplina un uso limitato dei farmaci antimicrobici: l'uso profilattico degli antibiotici come misura preventiva dovrebbe essere attuato solo se completamente giustificato da un veterinario, e quindi non per migliorare le prestazioni o compensare pratiche di allevamento inadeguate. </p>
<p class="contents">È preoccupante, infatti, il dato rilasciato dal Centro europeo per la prevenzione e il controllo delle malattie relativo al fatto che i batteri negli esseri umani, nel cibo e negli animali continuano a mostrare resistenza agli antimicrobici più diffusi, con la conseguenza che batteri come la salmonella continuano a proliferare in tutta Europa. Ritengo essenziale che si investa meglio e di più nella ricerca e nell'innovazione per lo sviluppo di nuovi farmaci.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-251-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124950.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jill Seymour (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>We in UKIP believe that a responsible use of all veterinary medicines in British livestock farming is vital to maintaining our high standards of food safety, animal health and welfare. We believe that all veterinary medicines including antibiotics should be used responsibly, under veterinary care and according to licensing conditions. We believe that the British Parliament should be able to legislate on this issue without being overruled by the unelected EU Commission.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-252-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124948.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Siôn Simon (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>It is clear that we need to have a regulation that provides better access to veterinary medicines, so I voted in favour of this because I believe that measures need to be taken to fight against antimicrobial resistance due to the routine use of prophylactic antibiotics, as well as aiming to reduce the administrative burden. We need to see an environment where this sector can innovate and develop the best medicinal products possible.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-252-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124927.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Branislav Škripek (ECR), </span></span>  <span class="italic">písomne ‒ </span>Som za to, aby sa znižovala spotreba antibiotík vo veterinárnej medicíne. Preto treba prijať opatrenia proti nadmernému, neuváženému a neodôvodnenému používaniu antibiotík aj v tejto oblasti, z tohto dôvodu som hlasoval za prijatie tohto uznesenia.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-252-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124756.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Davor Škrlec (Verts/ALE), </span></span>  <span class="italic">napisan. </span><span class="italic">‒ </span>Podržao sam ovaj prijedlog Uredbe jer ima potencijal pojednostavniti regulatorno okružje i smanjiti administrativni teret u izdavanju i upravljanju veterinarsko medicinskim proizvodima. Prijedlog će stimulirati razvoj novih veterinarskih lijekova te poticati njihovu Internet prodaju širom Europske unije.</p>
<p class="contents">Ova Uredba povisuje kriterije dobre uzgojne prakse i prakse upravljanja kako bi se pojačala dobrobit životinja. Veterinarski recepti će u budućnosti zahtijevati potpuni klinički pregled životinja, a ne samo dokaz stalnih zdravstvenih provjera. Potrebni su i bolji podaci o tome na koji se način, kada, gdje i zašto antimikrobici upotrebljavaju. Države članice se stoga obvezuju analizirati i objavljivati podatke o obujmu prodaje antimikrobika. Proizvodnja antimikrobika ima utjecaj i na okoliš, no ovom se Uredbom nažalost nije obvezalo proizvođače da prijavljuju podatke o tim utjecajima.</p>
<p class="contents">Veliki uspjeh je postignut u odobravanju upotrebe homeopatskih lijekova namijenjenih ljudima, za primjenu kod svih životinja, pa tako i kod onih koje se koriste za proizvodnju hrane.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-253-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96655.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Smolková (S&amp;D), </span></span>  <span class="italic">písomne ‒ </span>Kvôli skutočnosti, že výroba veterinárnych liekov je omnoho zložitejšia ako výroba liekov na humánne použitie, je trh s veterinárnymi liekmi príliš roztrieštený. Preto prišla Komisia v septembri 2014 s návrhom opatrení, ktorými by sa mal podporiť vývoj veterinárnych liekov a ich distribúcia. K tomuto návrhu nariadenia podal Európsky parlament viacero pozmeňujúcich návrhov, keďže niektoré otázky neboli dostatočne doriešené. Po vyše roku a pol vyjednávaní sa zdá, že by mohla súčasná podoba legislatívneho textu obsahovať všetky nevyhnutné opatrenia, a preto som pozmeňujúce návrhy podporila. Nariadenie by sa v budúcnosti malo týkať regulácie povoľovania veterinárnych liekov, ich výroby, uvádzania na trh, distribúcie a používania počas ich životnosti, ako aj farmakovigilancie. Zámerom Komisie je zlepšiť prístup k liekom, znížiť administratívnu záťaž, podporiť inováciu, zabezpečiť dobré fungovanie trhu, ale aj bojovať proti odolnosti voči antibiotikám. Práve otázka antibiotík je zásadnou pre verejné zdravie. Želanie Komisie zostaviť kľúčový zoznam antibiotík vyhradených pre humánnu medicínu musí vychádzať zo solídnych vedeckých kritérií. Zároveň by sa mal zakázať online predaj antibiotík, ako aj všetkých veterinárnych liekov na predpis, keďže takáto prax predstavuje pre verejné zdravie závažné riziko. Popri snahe zlepšiť trh s veterinárnymi liekmi je totiž nevyhnutné myslieť aj na vplyv na zdravie človeka a ochranu životného prostredia.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-253-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124860.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Renato Soru (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho espresso voto favorevole sulla proposta di regolamento sui medicinali veterinari, che aggiorna la disciplina europea in materia, al fine di proteggere la salute animale e umana contestualmente alla protezione dell'ambiente. </p>
<p class="contents">Rispetto alla proposta della Commissione che si concentra sulla disponibilità di medicinali veterinari e sulla semplificazione amministrativa, nel rispetto della salute pubblica e della tutela dell'ambiente, il testo votato oggi aggiunge un altro aspetto importante, la lotta contro la resistenza agli antibiotici. Come Parlamento chiediamo infatti di limitare l'uso preventivo degli antibiotici per gli animali d'allevamento, ovvero evitare di usare gli antibiotici come misura preventiva e in assenza di segni clinici d'infezione, o addirittura come strumento per migliorare le prestazioni di allevamento. </p>
<p class="contents">Come comunicato recentemente dal Centro europeo per la prevenzione e il controllo delle malattie (CEPCM), i batteri negli esseri umani, nel cibo e negli animali continuano a mostrare resistenza agli antimicrobici più diffusi, riducendo così le opzioni per il trattamento efficace di gravi infezioni. È quindi necessario, per gli esseri umani e per gli animali, avere quanto prima una chiara panoramica dell'utilizzo di tutti i medicinali antimicrobici, in modo da poter agire senza indugio per ridurne l'impiego scorretto e porre fine agli abusi.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-253-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124929.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivan Štefanec (PPE), </span></span>  <span class="italic">písomne ‒ </span>Aj oblasť veterinárnych liekov je potrebné prispôsobiť vedeckému pokroku, trhovým požiadavkám a hospodárskej situácii. Práve kvôli posilneniu ochrany verejného zdravia by mal v Únii existovať rámec na zlepšenie životných podmienok zvierat a ľahký prístup k účinným veterinárnym liekom. Zavedením dobrých chovateľských a riadiacich postupov sa totiž výrazne zníži riziko negatívneho vplyvu na verejné zdravie.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-253-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119435.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Davor Ivo Stier (PPE), </span></span>  <span class="italic">napisan. </span><span class="italic">‒ </span>U svjetlu stečenog iskustva i slijedom procjene funkcioniranja tržišta veterinarsko-medicinskih proizvoda koju je provela Komisija, pravni okvir za veterinarsko-medicinske proizvode potrebno je prilagoditi znanstvenom napretku, trenutačnim uvjetima na tržištu i gospodarskoj stvarnosti. Životinje mogu oboljeti od čitavog niza bolesti koje se mogu spriječiti ili liječiti. Utjecaj bolesti životinja i mjera potrebnih za njihovo suzbijanje može biti poguban za pojedinačne životinje, populacije životinja, posjednike životinja i gospodarstvo. </p>
<p class="contents">Bolesti životinja koje su prenosive na ljude isto tako mogu značajno utjecati na javno zdravlje. Stoga u Uniji mora biti na raspolaganju dovoljno djelotvornih veterinarsko-medicinskih proizvoda kako bi se osigurali visoki standardi zdravlja životinja i javnog zdravlja te razvoj sektora poljoprivrede i akvakulture. </p>
<p class="contents">Također treba uspostaviti farmakovigilancijsku bazu podataka na razini Unije u kojoj će se evidentirati i ujedinjavati informacije o štetnim događajima za sve veterinarsko-medicinske proizvode odobrene u Uniji. Baza podataka trebala bi poboljšati otkrivanje štetnih događaja te omogućiti i olakšati farmakovigilancijski nadzor i podjelu posla između nadležnih tijela, te sam stoga podržao izvješće.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-254-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4545.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Catherine Stihler (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>Labour MEPs support a ban on routine prophylactic use of antibiotics in farming to help fight antimicrobial resistance.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119434.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dubravka Šuica (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Veterinarsko-medicinskim proizvodima potrebno je posvetiti pažnju u jednakoj mjeri, pa čak i višoj, kao i za medicinske proizvode za ljudsku upotrebu. U stočarstvu je posebno bitno da su dostupni noviji i bolji lijekovi jer je od ključne važnosti da veterinarsko-medicinski proizvodi budu dostupni po razumnim cijenama za stočare. Adekvatni zakoni i regulacije u spomenutom području tako su korisni i Europski parlament mora pojednostavniti i razjasniti prijedlog Komisije. Istovremeno, provjere novih proizvoda, nadzor njihovih nuspojava i utjecaja na zdravlje životinja te utjecaji na javno zdravlje i okoliš nikako ne smiju biti umanjeni.</p>
<p class="contents">Podržala sam odgodu i nastavak pregovora na interinstitucionalnoj razini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125103.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Patricija Šulin (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Glasovala sem za poročilo o predlogu uredbe Evropskega parlamenta in Sveta o zdravilih za uporabo v veterinarski medicini.</p>
<p class="contents">Podpiram pristop, da je treba trg z zdravili za uporabo v veterinarski medicini ločiti od trga z zdravili za uporabo v humani medicini, ki deluje zelo drugače. Prav tako pozdravljam dejstvo, da želi Komisija brez žrtvovanja načel javnega zdravja in varstva okolja, povečati razpoložljivost zdravil ter poenostaviti upravne postopke.</p>
<p class="contents">Podpiram predlog spremembe, da se vzpostavijo strogi mehanizmi nadzora, zlasti za nadzor nad čezmejnimi veterinarskimi recepti, ki lahko v primeru nezakonite dejavnosti ali nespoštovanja kodeksa poklicnega ravnanja omogočijo odvračilne kazni ali sodni pregon. To pa zahteva boljše sodelovanje vseh 28 držav članic.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96920.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kay Swinburne (ECR), </span></span>  <span class="italic">in writing. ‒ </span>I support this report on new veterinary medicines legislation, which will stimulate innovation and provide new solutions to tackling animal diseases.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124689.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νεοκλής Συλικιώτης (</span></span>  <span class="bold">GUE</span><span class="bold">/</span><span class="bold">NGL</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Η έκθεση καθορίζει με σαφήνεια τις συνθήκες υπό τις οποίες επιτρέπεται να δίνονται συνταγές και να πωλούνται αντιβιοτικά. Υπερψηφίσαμε την έκθεση, καθώς η αγορά των κτηνιατρικών φαρμάκων πρέπει να διαχωρίζεται από την αγορά φαρμάκων για ανθρώπινη χρήση, αλλά ταυτόχρονα να διασφαλίζεται και η υγεία των ίδιων των ζώων από τη χρήση των φαρμάκων και αντιβιοτικών, χωρίς τη χρήση Γενετικά Τροποποιημένων Οργανισμών. Είναι σημαντικό οι κανόνες σχετικά με τα φαρμακευτικά προϊόντα για ανθρώπινη χρήση και οι κανόνες σχετικά με τα φάρμακα για κτηνιατρική χρήση να συμφωνούν σε αυτό το σημείο.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23821.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">József Szájer (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az állatgyógyászati készítményekről szóló rendelettervezet teljes körűen átdolgozza a hatályos szabályozást, amelyet ezidáig a 2001/82/EK irányelv és a 726/2004/EK rendelet keretében alkalmaztak. Az új javaslat célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt.</p>
<p class="contents">A jelenlegi jogszabályban foglaltakhoz képest számos, hazánk számára fontos előrelépést tartalmaz a tervezet. Az állatgyógyászati szektor jellemzőit figyelembe véve az új szabályozás ösztönzi a már engedélyezett készítmények további állatfajokra történő kiterjesztését. Fokozott adatvédelmet élveznek majd az új antimikrobiális szerek, illetve az ún. kevésbé fontos állatfajok részére kifejlesztett készítmények. A jelentés kiemelten kezeli a méhek számára engedélyezett gyógyszereket, 20 év adatvédelmi időt biztosítva ezeknek. A változások segíthetik új antibiotikumok megjelenését az állatgyógyászatban és javíthatják a készítmények elérhetőségét olyan, Magyarországon kiemelten fontos ágazatban is, mint a méhészet.</p>
<p class="contents">Noha van még javítanivaló a tervezeten ahhoz, hogy a szabályozással érintett ágazatok érdekeit maradéktalanul figyelembe vehessük, a jelentés kiváló alapot teremt a Tanáccsal folytatott trilógusokhoz. Jó lépés a megfelelő irányba. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124703.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tibor Szanyi (S&amp;D), </span></span>  <span class="italic">írásban. ‒ </span>A szavazatommal támogatott jelentés alapját képező rendelettervezet célja az állatgyógyászati készítmények engedélyezésének, gyártásának, forgalomba hozatalának, terjesztésének és felhasználásának szabályozása a gyógyszerek teljes életútja alatt, valamint az alkalmazandó farmakovigilanciai eljárás szabályozása.</p>
<p class="contents">A hatályos jogi keret alkalmazása során problémák merültek fel, többek között az állatgyógyászati készítmények elérhetőségének hiánya, az adminisztratív terhek, a belső piac működése és természetesen az antibiotikum-rezisztencia jelensége tekintetében. Éppen ezért volt szükséges egy új szabályozási keret kialakítása.</p>
<p class="contents">Az internetes forgalmazással kapcsolatban üdvözlendő, hogy a javaslat megerősíti, hogy amennyiben egy termék nem fogalmazható egy tagállamban, akkor annak forgalmazása online formában is tilos. Mindemellett a jelentés egy útmutató kidolgozására kéri fel az Európai Bizottságot ezzel kapcsolatban, mely véleményem szerint jó irányba mutat.</p>
<p class="contents">Egyetértek a jelentéssel, hogy az antimikrobiális szerek elleni küzdelemre vonatkozó rendelkezések terén sokkal ambiciózusabbnak kellene lenni, amit többek között a különféle kezelési típusok (gyógyító kezelés, tömeges kezelés és megelőző kezelés) meghatározásának beillesztésével, az antibakteriális szerek profilaktikus alkalmazásának tilalmával, illetve alternatív, nem antibiotikum tartalmú szerekkel érhetünk el. </p>
<p class="contents">Fontosnak tartom és támogatom, hogy meg kell erősíteni az innováció támogatását célzó ösztönző intézkedéseket. Az állatgyógyászati készítmények piaca rendkívül széttagolt, az ágazati szereplők így csekély mértékben motiváltak az innovációra és új termékek piaci bevezetésére.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-255-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124890.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Adam Szejnfeld (PPE), </span></span>  <span class="italic">na piśmie. ‒ </span>Świat powoli zmierza w kierunku epoki post-antybiotykowej. Po pierwsze, trzeba rozwiązać problem oporności na antybiotyki (AMR) w hodowli zwierząt. Należy zaprzestać profilaktycznego stosowania antybiotyków oraz zakazać stosowania krytycznych dla medycyny antybiotyków wśród zwierząt. </p>
<p class="contents">Przedstawione sprawozdanie zaprojektowano tak, aby podkreślić rolę lekarzy weterynarii oraz pozostałego personelu weterynaryjnego jako specjalistów w tej dziedzinie, poprzez ułatwienie ich pracy, a nie nakładanie dodatkowych obciążeń i regulacji tego zawodu. Konieczne jest również poprawienie jakości leczenia i ograniczenie stosowania antybiotyków, które nie zostały dopuszczone do sprzedaży, a także zapewnienie dostępności leków. </p>
<p class="contents">Reforma prawa weterynaryjnego produktów leczniczych jest niezwykle ważna dla wzmocnienia jednolitego rynku w tym sektorze, dlatego zdecydowałem się poprzeć zaprezentowane sprawozdanie.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-256-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28316.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Hannu Takkula (ALDE), </span></span>  <span class="italic">kirjallinen. ‒ </span>Äänestin mietinnön puolesta, koska se on edistysaskel erityisesti antibioottiresistenssin, eläinten hyvinvoinnin ja byrokratian vähentämisen osalta. Monessa maassa antibiootteja käytetään edelleen ennalta ehkäisevästi ilman todettua tautia, mikä ei ole oikein. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-256-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124813.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dario Tamburrano (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho votato a favore, anche se da una prospettiva particolare: sebbene la relazione guardi principalmente alla creazione del mercato unico per i farmaci veterinari, vi sono altre componenti che mi trovano d'accordo: la salvaguardia del benessere animale, l'aumento delle disponibilità di medicinali veterinari in tutta Europa, il passaggio da una cultura di cura di massa degli animali a una in cui agli animali vengono somministrate cure individuali come agli uomini.</p>
<p class="contents">Approvo soprattutto l'eliminazione della somministrazione di antibiotici agli animali d'allevamento per scopi profilattici o metafilattici. Gli antibiotici non sostituiscono decenti condizioni di vita per gli animali, sebbene troppo spesso gli allevatori ne fanno uso proprio al fine di risparmiare sui costi di gestione e di aumento delle rese.</p>
<p class="contents">La somministrazione massiccia e routinaria di antibiotici agli animali d'allevamento è legata alla crescente comparsa di ceppi di batteri resistenti agli antibiotici, il che comporta serie conseguenze per la salute umana. Gli antibiotici hanno salvato la vita almeno un paio di volte alla generalità degli esseri umani: sarebbe sciocco farli diventare sempre più inefficaci in cambio di qualche bistecca a buon mercato.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-256-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/29579.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Tarabella (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>Sur la plupart des points du dossier, je partage l'avis de madame Grossetête. En ce qui concerne la pharmacovigilance, la nouvelle approche de la Commission européenne basée sur la détection des risques est un progrès, à condition de ne pas transiger sur la santé publique. Un système se basant à la fois sur la soumission régulière de rapports périodiques de pharmacovigilance dans les toutes premières années de vie du produit, et seulement ensuite sur l'analyse de risques et la détection de signaux, paraît plus adapté.</p>
<p class="contents">La Commission propose de rendre plus facile l'utilisation hors AMM de médicaments humains pour traiter les animaux. Le texte laisse la responsabilité aux vétérinaires de décider de cette utilisation. Sans remettre en cause la responsabilité de ces derniers, la rapporteure demande à ce que cette possibilité soit mieux encadrée, en précisant que l'usage de médicaments humains ne peut se faire qu'en dernier ressort et si aucune alternative meilleure n'existe. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-256-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124706.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Pavel Telička (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>Healthy animals are an essential prerequisite for Europe’s agriculture, public health and environment. However, veterinary products have been difficult to access in small markets, their use plagued by heavy and sometimes unnecessary administration and there has been worrying resistance to antibiotics. In addition, medicine for animals and humans has been put into the same category, which is very confusing. I believe that the Commission’s proposal is an important step forward to remedy to this, which is why I voted in favour of it. It provides a good balance between consumer needs by improving access to medicinal products, simplifying administration while simultaneously providing incentives for the veterinary industry to encourage innovation, which is needed in this small and quite fragmented market.</p>
<p class="contents">It will also work on ensuring a functioning internal market. More importantly, it will tackle the growing antibiotic resistance by limiting the use of antibiotics, but also by allowing the use of homeopathic alternatives, and by defining who is entitled to prescribe veterinary medicine.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-257-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96697.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Valdemar Tomaševski (ECR), </span></span>  <span class="italic">raštu. ‒ </span>Kaip Žemės ūkio ir kaimo plėtros komiteto narys parėmiau šį pranešimą, nes pokyčių šiuo klausimu buvo laukiama jau senai. Europos Komisijos projektas dėl veterinarinių vaistų keičia nuostatas dėl šių vaistų. Šiuo dokumentu siekiama reglamentuoti veterinarinių vaistų leidimų suteikimą, gamybą, rinkodarą, veterinarinių vaistų platinimą ir naudojimą visu jų galiojimo laikotarpiu, taip pat jiems taikomą farmakologinio budrumo procesą. O vaistų saugumas yra svarbiausia, kadangi galutinis žemės ūkio produktų vartotojas visada yra žmogus. Apie tai reikia prisiminti kas kartą keičiant teisės nuostatas. Viskas rodo į tai, kad naujos nuostatos pagerins prieigą prie veterinarinių vaistų ir sumažins administracines naštas, ypač kalbant apie farmakologinį budrumą.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-257-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119431.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ruža Tomašić (ECR), </span></span>  <span class="italic">napisan. ‒ </span>U svjetlu stečenog iskustva i slijedom procjene funkcioniranja tržišta veterinarsko-medicinskih proizvoda koju je provela Komisija, pravni okvir za veterinarsko-medicinske proizvode potrebno je prilagoditi znanstvenom napretku, trenutačnim uvjetima na tržištu i gospodarskoj stvarnosti, zbog čega sam i podržala ovo izvješće. </p>
<p class="contents">Utjecaj bolesti životinja može biti poguban za pojedinačne životinje, populacije životinja, posjednike životinja i gospodarstvo. Stoga u Uniji mora biti na raspolaganju dovoljno djelotvornih veterinarsko-medicinskih proizvoda kako bi se osigurali visoki standardi zdravlja životinja i javnog zdravlja. Osim toga, ovo izvješće je također bitno radi borbe protiv antimikrobne rezistencije pa je stoga potrebno poduzimati niz mjera. Pravila o oglašavanju veterinarskih antimikrobika treba postrožiti, a zahtjevi u pogledu odobrenja moraju u dovoljnoj mjeri obuhvaćati rizike i koristi antimikrobnih veterinarsko-medicinskih proizvoda.</p>
<p class="contents">Iako sam glasovala pozitivno, smatram da ne treba u potpunosti zabraniti prodaju svih veterinarsko-medicinskih proizvoda putem interneta, već bi trebalo uvesti dodatne mjere za nadzor kojima bi se spriječila prodaja krivotvorenih lijekova i lijekova nedostatne kakvoće.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-257-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125104.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Romana Tomc (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Poročilo o predlogu uredbe Evropskega parlamenta in Sveta o zdravilih za uporabo v veterinarski medicini sem podprla, saj menim, da je nujno potrebna nova zakonodaja, ki bo povečala obseg raziskav, razvoja in spremljanja na področju zdravil.</p>
<p class="contents">Zaradi naraščajoče odpornosti bakterij na antibiotike je potrebno omejiti uporabo obstoječih protimikrobnih zdravil. Pogajanja o tej zakonodaji se morajo tako začeti čimprej.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-257-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/131749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Estefanía Torres Martínez (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Hemos votado A FAVOR de este informe dado que apunta a un mayor control tanto del ciclo de venta de los antibióticos como del uso de los mismos. Limita la venta en internet de medicinas que deberían venderse con prescripción médica, se limita y controla el uso de forma preventiva y se refiere a otras cuestiones que atañen a criterios de bienestar animal. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97203.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ramon Tremosa i Balcells (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>It is normal that technology advances over time and new drugs appear and existing legislation has to be updated and adapted to the new economic situation and the current market conditions. I support this proposal in order to improve the situation of farm animals and improve as well the protection of public health and the environment.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124758.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mylène Troszczynski (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Le projet de rapport vise à réglementer la mise sur le marché et la circulation des médicaments vétérinaires. Les grandes préoccupations qui ont sous-tendu les propositions sont la lutte contre l'antibiorésistance et l'assurance de la meilleure disponibilité possible des médicaments. </p>
<p class="contents">Sous cet objectif se cache en fait une libéralisation de la vente des médicaments, notamment par des sites de vente en ligne, soustrayant cette source de revenus aux vétérinaires, plus à même de délivrer les produits. </p>
<p class="contents">Même si ce rapport est plus restrictif que la proposition de la Commission, il ne respecte pas les intérêts de nos vétérinaires qui assurent un véritable travail de sentinelle sanitaire. Il autorise en outre la prescription de certains médicaments par des non-vétérinaires à cause de l'Angleterre, ce qui est inacceptable pour des raisons de santé publique (exemple de la vache folle).</p>
<p class="contents">J'ai donc voté CONTRE ce rapport. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/131750.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mihai Ţurcanu (PPE), </span></span>  <span class="italic">în scris. ‒ </span>Rezistența la antimicrobiene atât la oameni, cât și la animale, este o problemă de sănătate tot mai gravă în Uniunea Europeană și în întreaga lume. Este esențial atât pentru oameni, cât și pentru animale, să se stabilească o imagine clară a modului în care sunt folosite medicamentele antimicrobiene, pentru a putea reduce semnificativ folosirea acestora și a stopa toate abuzurile. Utilizarea responsabilă a antimicrobienilor în tratarea bolilor de origine bacteriană contribuie la controlul maladiilor care afectează sectorul creșterii animalelor. Folosirea lor abuzivă și excesivă în fermele de animale stimulează rezistența, care se poate răspândi la oameni în mai multe moduri, inclusiv prin alimente. Bolile pot fi prevenite prin punerea în aplicare a bunelor practici de biosecuritate, nutriție, igienă și confort animal. În niciun caz nu ar trebui permisă prescrierea unui medicament antibacterian fără să se stabilească un diagnostic clar de boală. Este necesar să se asigure că prospectul antimicrobienelor de uz veterinar conține avertismente și instrucțiuni adecvate, în special definiții clare ale diferitelor forme de tratament (tratament curativ, tratament de control și tratament preventiv) și să se interzică utilizarea profilactică a medicamentelor antibacteriene.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/131507.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miguel Urbán Crespo (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Hemos votado A FAVOR de este informe dado que apunta a un mayor control tanto del ciclo de venta de los antibióticos como del uso de los mismos. Limita la venta en internet de medicinas que deberían venderse con prescripción médica, se limita y controla el uso de forma preventiva y se refiere a otras cuestiones que atañen a criterios de bienestar animal. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124972.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ernest Urtasun (Verts/ALE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the report as it successfully strengthens the requirements for antimicrobials, in particular with regard to prophylaxis, metaphylaxis and data collection per farm.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96698.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Viktor Uspaskich (ALDE),</span></span>   <span class="italic">raštu</span><span class="bold">. –</span> Teisinė sistema, kuria reglamentuojami veterinariniai vaistai, turėtų būti atnaujinta atsižvelgiant į mokslo pažangos rezultatus, dabartines rinkos sąlygas ir ekonominę realybę, atsižvelgiant į gyvūnus, gamtą ir jų sąveiką su žmogumi.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0843"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97019.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivo Vajgl (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>The vote on the report on the proposal for a regulation on veterinary medicinal products was actually a vote on the request that this report be referred back to its competent committee. I voted in favour of the referral back to committee, which would allow some controversial issues to be hopefully clarified.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125032.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ramón Luis Valcárcel Siso (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>El informe establece la limitación del uso de los antibióticos al mismo tiempo que fomenta el desarrollo de nuevos productos para combatir la creciente resistencia de las bacterias a los medicamentos antimicrobianos, prohibiendo el tratamiento colectivo y preventivo de los animales y apoyando el impulso de la investigación en nuevas medicinas. Hablamos de un documento que ha sido objeto de un amplio debate y ha necesitado un consenso muy amplio, por lo que considero necesario votar a favor. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125100.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miguel Viegas (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Este regulamento contém aspetos positivos. Garantir a produção de medicamentos veterinários seguros, eficazes e acessíveis constitui um objetivo importante para os nossos produtores. A introdução da questão dos medicamentos genéricos, das resistências antimicrobianas ou dos pequenos mercados é um elemento importante que vai no sentido correto.</p>
<p class="contents">Pensamos, no entanto, que o mesmo poderia ir mais longe, não fosse a pressão das empresas multinacionais que pretendem alongar ao máximo os seus privilégios, capturando rendas monopolistas se possível até à eternidade.</p>
<p class="contents">Poderia ter-se ido mais longe numa maior generalização do método centralizado, a nosso ver o único que salvaguarda o interesse dos países mais pequenos e evita que as multinacionais disponibilizem os seus produtos apenas nos mercados mais rentáveis.</p>
<p class="contents">Sejamos, no entanto, claros. A grande preocupação com a segurança e com uma boa aplicação dos medicamentos veterinários não se resolve apenas com este regulamento: resolve-se atacando o problema na raiz, que reside numa PAC essencialmente produtivista que promove a monocultura intensiva e destrói a pequena e a média agricultura familiar europeia.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0968"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125001.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Harald Vilimsky (ENF), </span></span>  <span class="italic">schriftlich. ‒ </span>Die Berichterstatterin kann schlüssig darstellen, dass die vorgeschlagene Verordnung der Kommission – mit den von der Berichterstatterin gewünschten Änderungen – zur Erreichung der genannten Ziele beitragen kann. Daher unterstütze ich diesen Bericht.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-258-0984"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23894.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Anna Záborská (PPE), </span></span>  <span class="italic">písomne ‒ </span>Už v roku 2014 Európska komisia stanovila záväzok úplne prepracovať právne predpisy týkajúce sa veterinárnych liekov. Pri uplatňovaní platného právneho rámca nastali rôzne problémy. Jeden z najzávažnejších, ktorý sa bezprostredne týka človeka, je otázka odolnosti voči antibiotikám. </p>
<p class="contents">Tento návrh Európskej komisie je krokom správnym smerom. Oceňujem vôľu Komisie odlíšiť trh s veterinárnymi liekmi od trhu s humánnymi liekmi. Za správne považujem aj to, že sa kladie dôraz na dostupnosť liekov a zjednodušenie administratívy. Zároveň sú dodržané zásady verejného zdravia a ochrany životného prostredia. Podporila som preto tento návrh a zároveň som vďačná kolegyni Grossetête za jej komplexnú správu k nariadeniu o veterinárnych liekoch.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-259-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96763.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Pablo Zalba Bidegain (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Creo que el contenido de este informe es muy interesante, ya que me parece que está muy en línea con los objetivos de la Unión Europea por unificar legislaciones y mercados entre los Estados miembros. </p>
<p class="contents">En este caso, lo que se persigue es una armonización de leyes referentes a los medicamentos para animales, lo cual tendrá un claro impacto en la UE, ya que estamos hablando de un mercado relativamente amplio. </p>
<p class="contents">Gracias a las iniciativas propuestas, se conseguirá unificar los productos veterinarios, de modo que sean igualmente accesibles en todos los Estados, con las mismas características, lo cual agilizará y hará más efectivo el comercio de los mismos.</p>
<p class="contents">Por tanto, apoyo el informe y confío en que contribuirá a mejorar el proceso de cohesión de la UE.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-259-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124739.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Carlos Zorrinho (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>Votei a favor do relatório Grossetête, que procura banir a rotina do uso de antibióticos em animais saudáveis para ajudar a combater a resistência antimicrobiana.</p>
<p class="contents">O uso generalizado de antibióticos antimicrobianos na Europa não só levanta sérias preocupações de bem-estar animal, mas também representa uma ameaça real para a saúde humana e animal. A Europa apresenta hoje uma das taxas mais elevadas de resistência antimicrobiana do mundo. </p>
<p class="contents">Entre as medidas apoiadas pelo grupo socialista nesta matéria, destaco a proposta para a criação de um sistema harmonizado de prescrição digital em toda a Europa. A emissão e o controlo das receitas devem realizar-se a nível nacional, pelo menos até à instituição de um sistema da União que permita o controlo das receitas transfronteiras.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-259-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96933.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Milan Zver (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Glasoval sem za zakonodajni predlog, katerega namen je med drugim izboljšati dostop do veterinarskih zdravil, povečati spodbude za inovacije in raziskave, pravno urediti problem vse večje odpornosti na antibiotike ter upoštevati varstvo okolja.</p>
<p class="contents">Menim, da je dobro, da se postopki v Uniji v zvezi s pridobitvijo veterinarskega recepta harmonizirajo in da se omogoči priznavanje receptov med državami članicami.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
